<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Psychiatry</journal-id>
<journal-title>Frontiers in Psychiatry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Psychiatry</abbrev-journal-title>
<issn pub-type="epub">1664-0640</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpsyt.2023.1197987</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Psychiatry</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Differences in resting-state brain networks and gray matter between APOE &#x03B5;2 and APOE &#x03B5;4 carriers in non-dementia elderly</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Zhiyuan</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="fn0006" ref-type="author-notes"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pang</surname>
<given-names>Jing</given-names>
</name>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
<xref rid="fn0006" ref-type="author-notes"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2190752/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Ruizhi</given-names>
</name>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qi</surname>
<given-names>Jianjiao</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shi</surname>
<given-names>Xianglong</given-names>
</name>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Bin</given-names>
</name>
<xref rid="aff4" ref-type="aff"><sup>4</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1879819/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Man</surname>
<given-names>Xu</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Qingqing</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Sun</surname>
<given-names>Jinping</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<xref rid="c001" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1855931/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Institute of Integrative Medicine, The Affiliated Hospital of Qingdao University</institution>, <addr-line>Qingdao</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Radiology, The Affiliated Hospital of Qingdao University</institution>, <addr-line>Qingdao</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Emergency Medicine, The Affiliated Hospital of Qingdao University</institution>, <addr-line>Qingdao</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Neurology, The Affiliated Hospital of Qingdao University</institution>, <addr-line>Qingdao</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0007"><p>Edited by: Magdalena Sowa-Kucma, University of Rzeszow, Poland</p></fn>
<fn fn-type="edited-by" id="fn0008"><p>Reviewed by: Lei Gao, Wuhan University, China; Grace Lee, Loma Linda University, United States</p></fn>
<corresp id="c001">&#x002A;Correspondence: Jinping Sun, <email>sunjinping@qdu.edu.cn</email></corresp>
<fn id="fn0006" fn-type="equal"><p><sup>&#x2020;</sup>These authors have contributed equally to this work and share first authorship</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>08</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1197987</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>03</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>07</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2023 Wang, Pang, Zhou, Qi, Shi, Han, Man, Wang and Sun.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Wang, Pang, Zhou, Qi, Shi, Han, Man, Wang and Sun</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Background</title>
<p>Apolipoprotein E (APOE) &#x03B5;2 and APOE &#x03B5;4 are the most distinct alleles among the three APOE alleles, both structurally and functionally. However, differences in cognition, brain function, and brain structure between the two alleles have not been comprehensively reported in the literature, especially in non-demented elderly individuals.</p>
</sec>
<sec id="sec2">
<title>Methods</title>
<p>A neuropsychological test battery was used to evaluate the differences in cognitive performance in five cognitive domains. Independent component analysis (ICA) and voxel-based morphometry (VBM) were used separately to analyze resting-state functional magnetic resonance imaging (rs-fMRI) data and the structure MRI data between the two groups. Finally, correlations between differential brain regions and neuropsychological tests were calculated.</p>
</sec>
<sec id="sec3">
<title>Results</title>
<p>APOE &#x03B5;2 carriers had better cognitive performance in general cognitive, memory, attention, and executive function than APOE &#x03B5;4 carriers (all <italic>p</italic> &#x003C;&#x2009;0.05). In ICA analyses of rs-fMRI data, the difference in the resting-state functional connectivity (rsFC) between two groups is shown in 7 brain networks. In addition, VBM analyses of the T1-weighted image revealed that APOE &#x03B5;2 carriers had a larger thalamus and right postcentral gyrus volume and a smaller bilateral putamen volume than APOE &#x03B5;4 carriers. Finally, differences in brain function and structure may be the reason that APOE &#x03B5;2 carriers are better than APOE &#x03B5;4 carriers in cognitive performance.</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>These findings suggest that there are significant differences in brain function and structure between APOE &#x03B5;2 carriers and APOE &#x03B5;4 carriers, and these significant differences are closely related to their cognitive performance.</p>
</sec>
</abstract>
<kwd-group>
<kwd>resting-state functional magnetic resonance imaging</kwd>
<kwd>APOE &#x03B5;2</kwd>
<kwd>APOE &#x03B5;4</kwd>
<kwd>independent component analysis</kwd>
<kwd>voxel-based morphometry</kwd>
<kwd>non-dementia elderly</kwd>
</kwd-group>
<contract-num rid="cn1">2018YFC1315300</contract-num>
<contract-sponsor id="cn1">National Key R&#x0026;D Program of China</contract-sponsor>
<counts>
<fig-count count="5"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="55"/>
<page-count count="13"/>
<word-count count="9149"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Neuroimaging</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec5">
<label>1.</label>
<title>Introduction</title>
<p>The Apolipoprotein E (APOE) gene is an allele known to be closely associated with sporadic Alzheimer&#x2019;s disease (AD) (<xref ref-type="bibr" rid="ref1 ref2 ref3">1&#x2013;3</xref>), it was an isoform composed of three alleles &#x03B5;2, &#x03B5;3, and &#x03B5;4, and is located on chromosome 19q13.32 (<xref ref-type="bibr" rid="ref4">4</xref>). APOE &#x03B5;4 in the 3 alleles is the primary risk variant for AD and studies have shown that mice are replaced by human APOE &#x03B5;4 present serious brain atrophy and neuroinflammation than mice are replaced by human APOE &#x03B5;2 and &#x03B5;3 (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref6">6</xref>). APOE &#x03B5;2 has been considered as the neuroprotective and longevity gene, which reduces the risk of AD in comparison to APOE &#x03B5;3 and &#x03B5;4 (<xref ref-type="bibr" rid="ref7">7</xref>, <xref ref-type="bibr" rid="ref8">8</xref>). A study consisting of over 5,000 participants found that the likelihood of APOE &#x03B5;2 homozygotes is significantly lower in individuals with AD compared to those with other APOE alleles (<xref ref-type="bibr" rid="ref9">9</xref>).</p>
<p>Studies have shown that APOE &#x025B;3 is not only the most common but also has a slight effect on the carrier&#x2019;s cognitive function compared to other alleles (<xref ref-type="bibr" rid="ref10">10</xref>). Postmortem studies on patients with AD revealed that APOE &#x03B5;4 accelerated the accumulation of A&#x03B2; and plaque deposition in the brain (<xref ref-type="bibr" rid="ref11">11</xref>, <xref ref-type="bibr" rid="ref12">12</xref>), while APOE &#x03B5;2 decreased the A&#x03B2; and plaque deposition (<xref ref-type="bibr" rid="ref13">13</xref>). Based on the findings of these studies, APOE &#x03B5;2 and APOE &#x03B5;4 may affect the cognitive function of carriers via different regulations of the same pathological process (<xref ref-type="bibr" rid="ref7">7</xref>), thus, a direct comparison of the difference in the brain of carriers between these two genotypes may be more helpful in advancing our understanding about AD.</p>
<p>Since the discovery by Biswal et al. (<xref ref-type="bibr" rid="ref14">14</xref>) regarding synchronization patterns of low-frequency oscillatory signals in the sensorimotor cortex, it has opened the door for resting-state fMRI (<xref ref-type="bibr" rid="ref15 ref16 ref17 ref18">15&#x2013;18</xref>). Using rs-fMRI, Chen et al. (<xref ref-type="bibr" rid="ref19">19</xref>) reported decreased local rsFC on medial temporal areas in APOE &#x025B;4 carriers compared with APOE &#x025B;4 non-carriers. Using structure MRI, Wang et al. (<xref ref-type="bibr" rid="ref20">20</xref>) revealed that left hippocampal volumes of APOE &#x03B5;4 carriers were smaller than those of APOE &#x03B5;4 non-carriers. Numerous studies have found that brain function and structural damage in APOE &#x025B;4 carriers may affect their cognitive function compared with non-carriers, however, few studies have directly explored the differences in brain function and structure between APOE &#x025B;2 and APOE &#x025B;4 carriers. Therefore, directly exploring the differences in brain function and structure between APOE &#x025B;2 and APOE &#x025B;4 carriers may help us understand the reasons for the protective and impaired cognitive function associated with these two genotypes, the pathogenesis of AD, and discover novel cognitive-related imaging markers. However, APOE &#x025B;2 is a less common allele, the frequency is about 12% in Han Chinese or less (<xref ref-type="bibr" rid="ref21">21</xref>), which makes it harder to study the differences between the two genotypes, this might be the reason for the fewer studies exploring the differences between carriers of APOE &#x025B;2 and &#x025B;4 alleles (<xref ref-type="bibr" rid="ref7">7</xref>, <xref ref-type="bibr" rid="ref22">22</xref>, <xref ref-type="bibr" rid="ref23">23</xref>). In addition, a previous study has reported that APOE &#x03B5;2/&#x03B5;4 carriers still have a higher risk of AD (<xref ref-type="bibr" rid="ref24">24</xref>). The cognitive impairment of APOE &#x03B5;4 was much greater than the protective effect of APOE &#x03B5;2 (<xref ref-type="bibr" rid="ref25">25</xref>). The knowledge gained from previous studies makes us to speculate three assumptions about APOE &#x025B;2 and APOE &#x025B;4, meanwhile, rs-fMRI and structure MRI studies of these two genotypes have not been reported, especially in non-dementia elderly. we inferred that (i) cognition function of APOE &#x03B5;2 carriers is higher than APOE &#x03B5;4 carriers in non-dementia older, especially in the memory cognitive domain. (ii) Compared to subjects with APOE &#x03B5;4, APOE &#x03B5;2 carriers had increased rsFC in multiple brain networks, especially in DMN. (iii) Hippocampus volume of APOE &#x03B5;4 carriers is reduced relative to APOE &#x03B5;2 carriers obviously in structure MRI.</p>
<p>In this study, we examined the cognitive performance, resting-state networks (RSN) and grey matter (GM) between these two functionally opposite genotypes in elderly non-dementia carriers, and Independent component analysis (ICA) (<xref ref-type="bibr" rid="ref26">26</xref>) and voxel-based morphometry (VBM) (<xref ref-type="bibr" rid="ref27">27</xref>) were used. Finally, the correlation between differential brain regions after analysis and neuropsychological test scores were calculated.</p>
</sec>
<sec sec-type="methods" id="sec6">
<label>2.</label>
<title>Methods</title>
<sec id="sec7">
<label>2.1.</label>
<title>Participants</title>
<p>A total of 530 right-handed Han Chinese participants from Qingdao City were enrolled in the study, as part of the sub-cohort in the Beijing Aging Brain Rejuvenation Initiative (BABRI) study (<xref ref-type="bibr" rid="ref28">28</xref>). Only 63 subjects met the following criteria: (1) Mini-Mental Status Examination (MMSE) &#x2265;24; (2) aged 50&#x2013;80&#x2009;years; (3) clinically diagnosed as non-demented patients by an experienced physician, and a clinical dementia rating (CDR) of 0; (4) no previous or current medical and neurological disorders to impact cognition; (5) no abnormality in the MRI of the brain structure and no any contraindication of MRI; and (6) blood samples were collected successfully for subsequent genotyping, APOE &#x03B5;2 and &#x03B5;4 carriers. The study was approved by the Ethics Committee of The Affiliated Hospital of Qingdao University, and signed informed consent was obtained from all subjects.</p>
</sec>
<sec id="sec8">
<label>2.2.</label>
<title>Neuropsychological testing</title>
<p>All subjects were evaluated using Mini-Mental state examination (MMSE) to assess general cognitive function and a battery of neuropsychological tests to assess five cognitive domains that included memory, attention, visuospatial ability, language, and executive function. Each cognitive domain used two different types of neuropsychological test scales, that tests were conducted by an experienced psychologist. Neuropsychological test scales were as follows. (1) Memory: the Auditory Verbal Learning Test (AVLT) and the Rey Osterrieth Complex Figure test (ROCF; recall). (2) Attention: the Trail Making Test (TMT-A) and the Symbol Digit Modalities Test (SDMT). (3) Visuospatial ability: ROCF (copy) and Clock Drawing Test (CDT). (4) Language: Category Verbal Fluency Test (CVFT) and the Boston Naming Test (BNT). (5) Executive function: the TMT-B and the Stroop Color and Word Test (SCWT-C). The raw test scores were used in this study.</p>
<p>Since MMSE was the most commonly used cognitive screening tool, the definitions of the other tests were mainly introduced here. AVLT: Firstly, playing 12 words, then subjects were asked to quickly recall words that were heard, and the test was repeated three times in succession, AVLT(N1-N3); Secondly, 5&#x2009;min after completing AVLT(N1-N3), participants were asked to freely recall 12 words they had heard in the first step; Thirdly, 20&#x2009;min after completing AVLT(N4), participants were asked to freely recall 12 words that they heard in the first step. The number of words correctly recalled is the score for each section; AVLT(N1-N3), AVLT(N4), and AVLT(N5) reflect Immediate recall (IR), short delay recall (DR), and long DR, respectively (<xref ref-type="bibr" rid="ref29">29</xref>). ROCF: Show the ROCF standard figure to the participants, and tell them to copy it on the blank paper, the first 4 strokes with a red pen and the rest with a black pen, limited 5-10&#x2009;min, ROCF(copy) (<xref ref-type="bibr" rid="ref30">30</xref>). Record the completion time, and tell them to recall the figure after 20&#x2009;min, same procedure as before, ROCF(recall) (<xref ref-type="bibr" rid="ref30">30</xref>). TMT-A: In the TMT-A standard test paper, subjects were asked to connect from the number 1 in the order from small to large, and not lift the pen when connecting, the faster the better, and the limit of 5&#x2009;min (<xref ref-type="bibr" rid="ref31">31</xref>). TMT-B: In the TMT-B standard test paper, told the subjects to connect from the number 1 in accordance with the order from small to large, and pay attention to the outer border of the number, in accordance with the rule of &#x201C;one square and one circle alternately.&#x201D; Do not lift the pen when connecting and the faster the better. The duration of the TMT-A and TMT-B was the final score (<xref ref-type="bibr" rid="ref31">31</xref>). SDMT: The subjects were informed that each number (1&#x2013;9) corresponds to a different symbol, and the subjects were asked to fill in the symbol corresponding to the corresponding number in the SDMT standard test paper within 90&#x2009;s, and the correct number was the total score (<xref ref-type="bibr" rid="ref32">32</xref>). CDT: The subjects were asked to draw a watch face on the blank paper, and marked the numbers and hands, the time shown on the watch is 1:50, draw vertically, the first 6 strokes with a red pen, and the rest with a black pen (<xref ref-type="bibr" rid="ref33">33</xref>). CVFT contains three parts, Animal fluency, Vegetable fluency, and Fruit fluency. Each test takes 1&#x2009;min, and participants were asked to name as many animals, vegetables, or fruits per minute, as possible without repeating them, words repeated do not count toward the total score, and the sum of the three parts was the total score (<xref ref-type="bibr" rid="ref34">34</xref>). BNT: A total of 30 BNT series of standard charts were shown to the subjects, and the subjects were asked what the pictures were, and the number of correct answers was the final score (<xref ref-type="bibr" rid="ref35">35</xref>). SCWT includes three parts: A, B, and C. There were three cards with 50 items each and Card A is for reading Chinese characters printed in black (red, yellow, blue, and green), card B is for dots of four colors, and card C is for Chinese characters with inconsistent color and meaning. Each part of the test is evaluated by two indicators, namely time and the correct number. SCWT-A(time) and SCWT-A(correct), SCWT-B(time) and SCWT-B(correct), SCWT-C(time) and SCWT-C(correct), SCWT-C(time) and SCWT-C(correct) were extensively used to assess the ability to inhibit cognitive interference and executive function (<xref ref-type="bibr" rid="ref36">36</xref>).</p>
</sec>
<sec id="sec9">
<label>2.3.</label>
<title>Genotyping</title>
<p>APOE DNA was extracted from blood samples of subjects that based on standard procedures and the PCR (Applied Biosystems, Foster City, CA) was used for subsequent genotype characterization. Two single nucleotide polymorphism genotypes of APOE were divided into rs429358 and rs7412 as previously described (<xref ref-type="bibr" rid="ref37">37</xref>), and then APOE &#x03B5;2 carriers and APOE &#x03B5;4 carriers were differentiated based on rs429358 and rs7412. A total of 530 subjects were successfully genotyped. The proportion of each APOE genotype was as follows: &#x03B5;2/&#x03B5;2 (5/530, 0.94%), &#x03B5;2/&#x03B5;3 (64/530, 12.08%), &#x03B5;2/&#x03B5;4 (5/530, 0.94%), &#x03B5;3/&#x03B5;3 (367/530, 69.25%), &#x03B5;3/&#x03B5;4 (80/530, 15.09%), and &#x03B5;4/&#x03B5;4 (9/530, 1.70%). The frequency of &#x03B5;2, &#x03B5;3, and &#x03B5;4 was 7.45, 82.83, and 9.72%, respectively. Only 63 subjects met the final inclusion and exclusion criteria. There were 32 APOE &#x03B5;4 carriers (including 2 &#x03B5;2/&#x03B5;4, 26 &#x03B5;3/&#x03B5;4, and 4 &#x03B5;4/&#x03B5;4) and 31 APOE &#x03B5;2 carriers (including 1 &#x03B5;2/&#x03B5;2 and 30 &#x03B5;2/&#x03B5;3).</p>
</sec>
<sec id="sec10">
<label>2.4.</label>
<title>MRI data acquisition</title>
<p>All participants were scanned with a General Electric (GE) sigma HDX 3.0 Tesla scanner at the Affiliated Hospital of Qingdao University, including BOLD and T1-weighted MRI scans. During scanning, noise-reducing headphones and foam padding were used to reduce head motion and noise impact. Moreover, all subjects were asked to stay awake and close their eyes during scanning. An echo-planar imaging (EPI) sequence was used to acquire rs-fMRI data: 33 axial slices, repetition time (TR)&#x2009;=&#x2009;2,000&#x2009;ms, echo time (TE)&#x2009;=&#x2009;30&#x2009;ms, slice thickness&#x2009;=&#x2009;3.5&#x2009;mm, flip angle&#x2009;=&#x2009;90&#x00B0;, matrix&#x2009;=&#x2009;64 &#x00D7; 64, 240 volumes and field of view (FOV)&#x2009;=&#x2009;200&#x2009;mm &#x00D7; 200&#x2009;mm. High-resolution T1-weighted images were acquired using a magnetization-prepared rapid gradient-echo (MPRAGE) sequence: 176 sagittal slices, TR&#x2009;=&#x2009;1,900&#x2009;ms, TE&#x2009;=&#x2009;3.44&#x2009;ms, voxel size: 1&#x2009;mm&#x2009;&#x00D7;&#x2009;1&#x2009;mm&#x2009;&#x00D7;&#x2009;1&#x2009;mm, acquisition matrix&#x2009;=&#x2009;256&#x2009;&#x00D7;&#x2009;256, slice thickness&#x2009;=&#x2009;1&#x2009;mm, FOV&#x2009;=&#x2009;256&#x2009;&#x00D7;&#x2009;256&#x2009;mm (<xref ref-type="bibr" rid="ref38">38</xref>).</p>
</sec>
<sec id="sec11">
<label>2.5.</label>
<title>Data preprocessing of rs-fMRI</title>
<p>RESTplus<xref rid="fn0001" ref-type="fn"><sup>1</sup></xref> is a practical toolbox of rs-fMRI preprocessing based on Statistical parametric mapping version 12 (SPM12)<xref rid="fn0002" ref-type="fn"><sup>2</sup></xref> and MATLAB2013b. RESTplus was used to preprocess all rs-fMRI data before statistical analysis. (1) Raw data was converted into a NIFTI format by dcm2nii.<xref rid="fn0003" ref-type="fn"><sup>3</sup></xref> (2) The first 10 points were removed from all time points to dispel noise impact and acquire more stable data. (3) Slice timing correction was implemented, which means the remaining 230 volumes were corrected for the acquisition time difference between slices. (4) To correct possible head motion during the rs-fMRI data acquisition, the between-frame realignment was performed the head motion parameter of frame displacement (FD) to be included in the statistical model was computed to further account for the movement effect. Translational or rotational motion parameters were less than 2&#x2009;mm or 2&#x00B0;, respectively. (5) Spatial normalization of T1-weighted images to a Montreal Neurological Institute (MNI) template space was performed using the DARTEL algorithm and resampled to 3&#x2009;mm x 3&#x2009;mm voxels. (6) The final preprocessing step before ICA is Gaussian smoothing, which was applied to smooth the data based on the full-width at half maximum (FWHM) [6 6 6] for normal distribution.</p>
</sec>
<sec id="sec12">
<label>2.6.</label>
<title>Determination of resting state networks</title>
<p>In short, ICA like a machine of classification can sort out some synchronously activated brain regions according to the similarity of BOLD signals. These brain regions cooperate in the resting state and thus are called RSNs (<xref ref-type="bibr" rid="ref15">15</xref>, <xref ref-type="bibr" rid="ref17">17</xref>, <xref ref-type="bibr" rid="ref39">39</xref>). ICA is a method used to obtain components with high temporal similarity and elevated spatial similarity. The Group ICA/IVA of fMRI toolbox (GIFT V3.0b, <ext-link xlink:href="https://trendscenter.org/software/" ext-link-type="uri">https://trendscenter.org/software/</ext-link>) based on MATLAB2013b was used to obtain independent components (ICs) of APOE &#x03B5;2 and &#x03B5;4 carriers, respectively. Processing steps were as follows (1) &#x201C;Minimum description length&#x201D; criterion was used to estimate the number of ICs of the two groups, respectively. For every subject, the estimated components were calculated, and the mean of all the estimated components was taken. Thirty-five ICs were identified in APOE &#x03B5;2 carriers and 39 ICs were identified in APOE &#x03B5;4 carriers. (2) The &#x201C;Infomax algorithm&#x201D; was used to calculate the ICs of the two groups, respectively. &#x201C;ICASSO&#x201D; was used to carry out group-ICA. ICA was run 100 times and the best estimate for each component is used. (3) All steps were run, including Parameter Initialization, Data Reduction, Calculate ICA, Back Reconstruction, Calibrate Components, and Group Stats. Finally, the 35 ICs and 39 ICs of the two groups were obtained. ICs consist of the spatial map that represents brain activity intensity of voxel and the time course that represents the waveform of brain activity, which was extracted from every subject. Lastly, the intensity values of the spatial map were converted to Z-values (<xref ref-type="bibr" rid="ref40">40</xref>) that is deemed to be the mightily effective way to measure the rsFC of intranetwork (<xref ref-type="bibr" rid="ref41">41</xref>) as well as spatial maps was used to screen RSNs. Two complementary approaches were used in to identify the RSNs (<xref ref-type="bibr" rid="ref42">42</xref>): (1) calculation of the correlation coefficient based on GIFT between ICs and the RSN template (FIND Lab at Stanford University), the maximum spatial correlation coefficient is considered strong evidence for selected ICs and (2) visual screening and inspection of which brain region similarity between the obtained ICs and RSN templates. Using the two approaches described above, we obtained eight RSNs that included Auditory Network (AN), Dorsal Attention Network (DAN), Default Mode Network (DMN), Left Executive Control Network (LECN), Right Executive Control Network (RECN), Somatomotor Network (SMN), Ventral Attention Network (VAN), and Visual Network (VN). The one-sample t-test and cluster-wise family-wise error (FWE) correction (<italic>p</italic> &#x003C;&#x2009;0.05) were carried out for each RSN of the two groups to determine the true active brain regions. The spatial map of RSNs is shown in <xref rid="fig1" ref-type="fig">Figure 1</xref>. An &#x201C;Image Calculator&#x201D; in SPM12 was used to calculate the intersection mask that limits the scope of intra-network analysis between the two groups.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p><bold>(A)</bold> Resting-state brain network map in APOE &#x03B5;2 carriers; <bold>(B)</bold> Resting-state brain network map in APOE &#x03B5;4 carriers. AN, auditory network; DAN, dorsal attention network; DMN, default mode network; LECN, left executive control network; RECN, right executive control network; SMN, somatomotor network; VAN, ventral attention network; VN, visual network.</p>
</caption>
<graphic xlink:href="fpsyt-14-1197987-g001.tif"/>
</fig>
</sec>
<sec id="sec13">
<label>2.7.</label>
<title>Data preprocessing of structure MRI</title>
<p>VBM8 is a widely accepted toolbox based on SPM8 (See text footnote 2) in the field of neuroimaging research to characterize the regional gray matter volume (GMV). VBM8 was used to compute the GMV of all subjects (<xref ref-type="bibr" rid="ref27">27</xref>). As previously described, the raw image was converted into a NIFTI format by dcm2nii. (See text footnote 3) The CheckReg tool in SPM8 was used to check the image quality to ensure that there was no obvious abnormality in the T1-weighted image. T1-weighted images were normalized to the MNI space using the DARTEL algorithm in VBM8, then the bias field correction was performed to prepare for segmentation. The image quality was checked again. Next, the image was segmented into GMV, white matter volume (WMV), and cerebrospinal fluid (CSF), which together make up the total intracranial volume (TIV). Finally, the image was modulated and smoothed with FWHM [8 8 8] before further statistical analysis.</p>
</sec>
<sec id="sec14">
<label>2.8.</label>
<title>RSFC analyses and GMV analyses between two groups</title>
<p>In the rsFC analyses, two-sample t-test based on SPM12 was used to compare the difference of rsFC in each RSNs map between the two groups, that is intra-network analyses. AN of APOE &#x03B5;2 carriers compared with AN of APOE &#x03B5;4 carriers, and so on. Previously calculated intersection mask was used to limit the statistic range and age, gender, and education level as a covariate. The final result uses cluster-wise FWE correction (voxel-wise <italic>p</italic> &#x003C;&#x2009;0.001 and cluster-wise <italic>p</italic> &#x003C;&#x2009;0.05) to remove false positive results. Regions of the brain where &#x03B5;2 carriers have higher rsFC in all brain networks than &#x03B5;4 carriers are defined as ROI-A and where &#x03B5;2 carriers had lower rsFC in all brain networks than &#x03B5;4 carriers were defined as ROI-B.</p>
<p>In GMV analyses, two-sample t-test based on SPM8 was used to compare the difference of the whole brain in GMV between the two groups, age, gender, education level and TIV as covariates, GM mask was used to limit the statistic range in the whole brain. Cluster-wise FWE correction (voxel-wise <italic>p</italic> &#x003C;&#x2009;0.001 and cluster-wise <italic>p</italic> &#x003C;&#x2009;0.05) is also used for the final result. After GMV analyses of the whole brain, differential brain regions were considered as ROIs, respectively.</p>
</sec>
<sec id="sec15">
<label>2.9.</label>
<title>Statistical analysis</title>
<p>The two-sample t-test was utilized to analyze differences in age, education, and neuropsychology test between the two groups, and the Chi-square test was used to analyze the gender difference. Data were analyzed using IBM SPSS Statistics 23.0 software (IBM Corp., Armonk, NY), and <italic>p</italic> &#x003C;&#x2009;0.05 was considered statistically significant. The values of ROIs after intranet-work rsFC analyses and GMV analyses of the whole brain were extracted by RESTplus utilities &#x201C;extracted regions of interest (ROI) signals,&#x201D; and then SPSS 23.0 was used to calculate the Partial correlation coefficients between all neuropsychological test scores and ROIs based on the whole sample and controlling age, gender, and education level. In multiple Partial correlation analysis, false discovery rate (FDR) correction based on the function of Matlab2013b was used to control false positives, FDR value&#x003C;0.05 was considered as significance.</p>
</sec>
</sec>
<sec sec-type="results" id="sec16">
<label>3.</label>
<title>Results</title>
<sec id="sec17">
<label>3.1.</label>
<title>Demographic and neuropsychological test</title>
<p>No significant differences in age, gender, and years of education were found between the two groups (<italic>p</italic> &#x003E;&#x2009;0.05). Demographic and neuropsychological test scores data are summarized in <xref rid="tab1" ref-type="table">Table 1</xref>. Although all subjects were from a non-dementia population, APOE &#x03B5;2 carriers still had higher MMSE scores in general cognitive situations, compared with APOE &#x03B5;4 carriers (<italic>p</italic> &#x003C;&#x2009;0.001). Moreover, both AVLT (N1-N3) and ROCF (recall) showed significant differences in the two memory cognitive domain tests (<italic>p</italic> &#x003C;&#x2009;0.05). The first assumption proposed previously is that the cognition function of APOE &#x03B5;2 carriers is higher than APOE &#x03B5;4 carriers in non-dementia older, especially in the memory cognitive domain, which was verified. The SDMT test of the attention cognitive domain and the SCWT-C (time) test of the executive function cognitive domain also showed significant differences between the two groups (<italic>p</italic> &#x003C;&#x2009;0.05). No difference in the language cognitive domain and the visuospatial cognitive domain was found between &#x03B5;2 and &#x03B5;4 carriers (<italic>p</italic> &#x003E;&#x2009;0.05).</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Demographic and neuropsychological data of the all subjects.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="top">&#x03B5;2 carriers (<italic>n</italic> =&#x2009;31)</th>
<th align="center" valign="top">&#x03B5;4 carriers (<italic>n</italic> =&#x2009;32)</th>
<th align="center" valign="top">statistics</th>
<th align="center" valign="top"><italic>p</italic>-value</th></tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Male/Female</td>
<td align="center" valign="middle">12/19</td>
<td align="center" valign="middle">11/21</td>
<td align="center" valign="middle">&#x03C7;2&#x2009;=&#x2009;0.128</td>
<td align="center" valign="middle">0.721<xref rid="tfn2" ref-type="table-fn"><sup>b</sup></xref></td></tr>
<tr>
<td align="left" valign="middle">Age (years)</td>
<td align="center" valign="middle">62.19&#x2009;&#x00B1;&#x2009;8.36 (50&#x2013;76)</td>
<td align="center" valign="middle">65.25&#x2009;&#x00B1;&#x2009;7.28 (51&#x2013;78)</td>
<td align="center" valign="middle">&#x2212;1.549</td>
<td align="center" valign="middle">0.127<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td></tr>
<tr>
<td align="left" valign="middle">Education (years)</td>
<td align="center" valign="middle">11.50&#x2009;&#x00B1;&#x2009;3.60 (2&#x2013;20)</td>
<td align="center" valign="middle">11.50&#x2009;&#x00B1;&#x2009;3.94 (4&#x2013;21)</td>
<td align="center" valign="middle">0.000</td>
<td align="center" valign="middle">1.000<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td></tr>
<tr>
<td align="left" valign="middle" colspan="5">General mental status</td></tr>
<tr>
<td align="left" valign="middle">MMSE</td>
<td align="center" valign="middle">28.07&#x2009;&#x00B1;&#x2009;1.84 (24&#x2013;30)</td>
<td align="center" valign="middle">26.13&#x2009;&#x00B1;&#x2009;2.00 (24&#x2013;30)</td>
<td align="center" valign="middle">4.253</td>
<td align="center" valign="middle">&#x003C;0.001<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td></tr>
<tr>
<td align="left" valign="middle" colspan="5">Memory</td></tr>
<tr>
<td align="left" valign="middle">AVLT(N1-N3)</td>
<td align="center" valign="middle">17.52&#x2009;&#x00B1;&#x2009;5.10 (2&#x2013;27)</td>
<td align="center" valign="middle">14.34&#x2009;&#x00B1;&#x2009;6.20 (3&#x2013;28)</td>
<td align="center" valign="middle">2.125</td>
<td align="center" valign="middle">0.031<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td></tr>
<tr>
<td align="left" valign="middle">AVLT(N4)</td>
<td align="center" valign="middle">5.16&#x2009;&#x00B1;&#x2009;2.46 (1&#x2013;11)</td>
<td align="center" valign="middle">3.88&#x2009;&#x00B1;&#x2009;3.58 (0&#x2013;12)</td>
<td align="center" valign="middle">1.656</td>
<td align="center" valign="middle">0.103<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td></tr>
<tr>
<td align="left" valign="middle">AVLT(N5)</td>
<td align="center" valign="middle">4.16&#x2009;&#x00B1;&#x2009;2.45 (0&#x2013;9)</td>
<td align="center" valign="middle">3.47&#x2009;&#x00B1;&#x2009;3.52 (0&#x2013;12)</td>
<td align="center" valign="middle">0.904</td>
<td align="center" valign="middle">0.370<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td></tr>
<tr>
<td align="left" valign="middle">ROCF(recall)</td>
<td align="center" valign="middle">14.77&#x2009;&#x00B1;&#x2009;8.53 (1&#x2013;34)</td>
<td align="center" valign="middle">9.63&#x2009;&#x00B1;&#x2009;8.59 (0&#x2013;34)</td>
<td align="center" valign="middle">2.386</td>
<td align="center" valign="middle">0.020<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td></tr>
<tr>
<td align="left" valign="middle" colspan="5">Attention</td></tr>
<tr>
<td align="left" valign="middle">SDMT</td>
<td align="center" valign="middle">37.29&#x2009;&#x00B1;&#x2009;14.66 (13&#x2013;66)</td>
<td align="center" valign="middle">28.47&#x2009;&#x00B1;&#x2009;11.55 (2&#x2013;53)</td>
<td align="center" valign="middle">2.658</td>
<td align="center" valign="middle">0.010<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td></tr>
<tr>
<td align="left" valign="middle">TMT-A</td>
<td align="center" valign="middle">57.03&#x2009;&#x00B1;&#x2009;27.28 (26&#x2013;138)</td>
<td align="center" valign="middle">82.65&#x2009;&#x00B1;&#x2009;69.95 (29&#x2013;438)</td>
<td align="center" valign="middle">&#x2212;1.904</td>
<td align="center" valign="middle">0.062<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td></tr>
<tr>
<td align="left" valign="middle" colspan="5">Visuospatial</td></tr>
<tr>
<td align="left" valign="middle">CDT</td>
<td align="center" valign="middle">23.10&#x2009;&#x00B1;&#x2009;5.17 (14&#x2013;30)</td>
<td align="center" valign="middle">21.13&#x2009;&#x00B1;&#x2009;7.85 (2&#x2013;29)</td>
<td align="center" valign="middle">1.174</td>
<td align="center" valign="middle">0.245<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td></tr>
<tr>
<td align="left" valign="middle">ROCF (copy)</td>
<td align="center" valign="middle">33.65&#x2009;&#x00B1;&#x2009;4.42 (18&#x2013;38)</td>
<td align="center" valign="middle">30.47&#x2009;&#x00B1;&#x2009;9.12 (2&#x2013;36)</td>
<td align="center" valign="middle">1.749</td>
<td align="center" valign="middle">0.085<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td></tr>
<tr>
<td align="left" valign="middle" colspan="5">Language</td></tr>
<tr>
<td align="left" valign="middle">CVFT</td>
<td align="center" valign="middle">43.55&#x2009;&#x00B1;&#x2009;8.06 (17&#x2013;57)</td>
<td align="center" valign="middle">38.59&#x2009;&#x00B1;&#x2009;11.53 (22&#x2013;74)</td>
<td align="center" valign="middle">1.971</td>
<td align="center" valign="middle">0.053<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td></tr>
<tr>
<td align="left" valign="middle">BNT</td>
<td align="center" valign="middle">23.55&#x2009;&#x00B1;&#x2009;4.13 (14&#x2013;30)</td>
<td align="center" valign="middle">21.97&#x2009;&#x00B1;&#x2009;4.58 (12&#x2013;28)</td>
<td align="center" valign="middle">1.437</td>
<td align="center" valign="middle">0.156<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td></tr>
<tr>
<td align="left" valign="middle" colspan="5">Executive function</td></tr>
<tr>
<td align="left" valign="middle">TMT-B</td>
<td align="center" valign="middle">151.42&#x2009;&#x00B1;&#x2009;59.29 (67&#x2013;316)</td>
<td align="center" valign="middle">177.16&#x2009;&#x00B1;&#x2009;53.94 (92&#x2013;326)</td>
<td align="center" valign="middle">&#x2212;1.803</td>
<td align="center" valign="middle">0.076<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td></tr>
<tr>
<td align="left" valign="middle">SCWT-C (time)</td>
<td align="center" valign="middle">79.94&#x2009;&#x00B1;&#x2009;25.25 (48&#x2013;150)</td>
<td align="center" valign="middle">99.63&#x2009;&#x00B1;&#x2009;38.51 (29&#x2013;223)</td>
<td align="center" valign="middle">&#x2212;2.392</td>
<td align="center" valign="middle">0.020<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td></tr>
<tr>
<td align="left" valign="middle">SCWT-C (correct)</td>
<td align="center" valign="middle">46.97&#x2009;&#x00B1;&#x2009;3.43 (35&#x2013;50)</td>
<td align="center" valign="middle">45.03&#x2009;&#x00B1;&#x2009;5.78 (21&#x2013;50)</td>
<td align="center" valign="middle">1.610</td>
<td align="center" valign="middle">0.113<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td></tr>
</tbody>
</table>
<table-wrap-foot>
<p>The raw scores of all neuropsychological were shown as the mean&#x2009;&#x00B1;&#x2009;standard deviation. The data range was also provided in parentheses. MMSE, mini-mental state examination; AVLT, auditory verbal learning Test; ROCF, Rey-Osterrieth complex figure; SDMT, symbol digit modalities Test; TMT, trail making test; SCWT, stroop color, and word test; CVFT, category verbal fluency test. BNT, boston naming test. CDT, clock drawing test.</p>
<fn id="tfn1">
<label>a</label>
<p>The <italic>p</italic>-values were obtained by two-sample t-test.</p>
</fn>
<fn id="tfn2">
<label>b</label>
<p>The <italic>p</italic>-value was obtained by the chi-square test.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec18">
<label>3.2.</label>
<title>Difference in RSNs between the two groups</title>
<p>A two-sample t-test and cluster-wise FWE correction showed a significant difference in brain regions of AN, DAN, DMN, LECN, SMN, VAN, and VN (<italic>p</italic> &#x003C;&#x2009;0.05) and no difference in RECN. The difference in the brain regions of the two groups is shown in <xref rid="fig2" ref-type="fig">Figure 2</xref>, and detailed information on differential brain regions after the correction is summarized in <xref rid="tab2" ref-type="table">Table 2</xref>. In the AN, compared with &#x03B5;4 carriers, &#x03B5;2 carriers exhibited increased rsFC in the left Heschl&#x2019;s gyrus (HES.L), right Rolandic operculum (ROL.R), and decreased rsFC in the right superior temporal gyrus (STG.R), left middle temporal gyrus (MTG.L). In the DAN, &#x03B5;2 carriers presented increased rsFC in the bilateral inferior parietal, but supramarginal and angular gyrus (IPL.L, IPL.R), and decreased rsFC in the left superior occipital gyrus (SOG.L), right middle occipital gyrus (MOG.R) relative to &#x03B5;4 carriers. In DMN, compared with &#x03B5;4 carriers, &#x03B5;2 carriers exhibited increased rsFC in the left calcarine fissure and surrounding cortex (CAL.L), and decreased rsFC in the left cuneus (CUN.L), right precuneus (PCUN.R). In the LECN, &#x03B5;2 carriers presented increased rsFC in the IPL.L, right angular gyrus (ANG.R), left middle frontal gyrus (MFG.L) and decreased rsFC in the MTG.L, left inferior frontal gyrus, orbital part (ORBinf.L) relative to &#x03B5;4 carriers. In the SMN, compared with &#x03B5;4 carriers, &#x03B5;2 carriers exhibited increased rsFC in the left precuneus (PCUN.L), and decreased in the left precentral (PreCG.L), left supplementary motor area (SMA.L). In the VAN, &#x03B5;2 carriers presented increased rsFC in the left supramarginal gyrus (SMG.L) and decreased rsFC in the right inferior temporal gyrus (ITG.R), right middle temporal gyrus (MTG.R), and right superior temporal gyrus (STG.R) relative to &#x03B5;4 carriers. In the VN, compared with &#x03B5;4 carriers, &#x03B5;2 carriers exhibited increased rsFC in the left lingual gyrus (LING.L) and decreased rsFC in the right calcarine fissure, and surrounding cortex (CAL.R).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p><bold>(A)</bold> Differential brain regions of rsFC between APOE &#x03B5;2 carriers and APOE &#x03B5;4 carriers in 7 resting-state brain networks. <bold>(B)</bold> Red: ROI-A; Blue: ROI-B; AN, auditory network; DAN, dorsal attention network; DMN, default mode network; LECN, left executive control network; SMN, somatomotor network; VAN, ventral attention network; VN, visual network.</p>
</caption>
<graphic xlink:href="fpsyt-14-1197987-g002.tif"/>
</fig>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Information of the brain regions after rsFC analyses.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">ROI</th>
<th align="left" valign="top">RSN</th>
<th align="left" valign="top">Brain regions</th>
<th align="center" valign="top">Cluster size</th>
<th align="center" valign="top">Coordinates (X Y Z)</th>
<th align="center" valign="top">Peak T-value</th></tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">A</td>
<td align="left" valign="middle">AN</td>
<td align="left" valign="middle">HES.L</td>
<td align="center" valign="middle">34</td>
<td align="center" valign="middle">&#x2212;48 &#x2212;12 9</td>
<td align="center" valign="middle">5.8163</td>
<td/>
<td align="left" valign="middle">ROL.R</td>
<td align="center" valign="middle">24</td>
<td align="center" valign="middle">48 &#x2212;9 12</td>
<td align="center" valign="middle">5.3038</td>
<td align="left" valign="middle">DAN</td>
<td align="left" valign="bottom">IPL.L</td>
<td align="center" valign="middle">131</td>
<td align="center" valign="middle">&#x2212;39 &#x2212;48 57</td>
<td align="center" valign="middle">7.595</td>
<td/>
<td align="left" valign="bottom">IPL.R</td>
<td align="center" valign="middle">166</td>
<td align="center" valign="middle">48 &#x2212;33 48</td>
<td align="center" valign="middle">10.9269</td>
<td align="left" valign="middle">DMN</td>
<td align="left" valign="middle">CAL.L</td>
<td align="center" valign="middle">82</td>
<td align="center" valign="middle">&#x2212;6 &#x2212;63 15</td>
<td align="center" valign="middle">4.8612</td>
<td align="left" valign="middle">LECN</td>
<td align="left" valign="middle">IPL.L</td>
<td align="center" valign="middle">112</td>
<td align="center" valign="middle">&#x2212;36 &#x2212;78 42</td>
<td align="center" valign="middle">6.7337</td>
<td/>
<td align="left" valign="middle">ANG.R</td>
<td align="center" valign="middle">22</td>
<td align="center" valign="middle">48 &#x2212;63 45</td>
<td align="center" valign="middle">5.3185</td>
<td/>
<td align="left" valign="middle">MFG.L</td>
<td align="center" valign="middle">40</td>
<td align="center" valign="middle">&#x2212;27 24 54</td>
<td align="center" valign="middle">6.2092</td>
<td align="left" valign="middle">SMN</td>
<td align="left" valign="middle">PCUN,L</td>
<td align="center" valign="middle">61</td>
<td align="center" valign="middle">&#x2212;3 &#x2212;60 57</td>
<td align="center" valign="middle">5.6261</td>
<td align="left" valign="middle">VAN</td>
<td align="left" valign="middle">SMG.L</td>
<td align="center" valign="middle">49</td>
<td align="center" valign="middle">&#x2212;57 &#x2212;51 27</td>
<td align="center" valign="middle">5.4305</td>
<td align="left" valign="middle">VN</td>
<td align="left" valign="middle">LING.L</td>
<td align="center" valign="middle">292</td>
<td align="center" valign="middle">&#x2212;9 &#x2212;63 6</td>
<td align="center" valign="middle">7.2004</td></tr>
<tr>
<td align="left" valign="top">B</td>
<td align="left" valign="middle">AN</td>
<td align="left" valign="middle">STG.R</td>
<td align="center" valign="middle">64</td>
<td align="center" valign="middle">63 &#x2212;24 12</td>
<td align="center" valign="middle">&#x2212;5.2101</td>
<td/>
<td align="left" valign="middle">MTG.L</td>
<td align="center" valign="middle">15</td>
<td align="center" valign="middle">&#x2212;48 &#x2212;51 9</td>
<td align="center" valign="middle">&#x2212;4.6516</td>
<td align="left" valign="middle">DAN</td>
<td align="left" valign="middle">SOG.L</td>
<td align="center" valign="middle">131</td>
<td align="center" valign="middle">&#x2212;21 &#x2212;75 33</td>
<td align="center" valign="middle">&#x2212;7.1761</td>
<td/>
<td align="left" valign="middle">MOG.R</td>
<td align="center" valign="middle">258</td>
<td align="center" valign="middle">33 &#x2212;75 42</td>
<td align="center" valign="middle">&#x2212;10.5267</td>
<td align="left" valign="middle">DMN</td>
<td align="left" valign="middle">CUN.L</td>
<td align="center" valign="middle">17</td>
<td align="center" valign="middle">&#x2212;6 &#x2212;78 36</td>
<td align="center" valign="middle">&#x2212;4.3115</td>
<td/>
<td align="left" valign="middle">PCUN.R</td>
<td align="center" valign="middle">34</td>
<td align="center" valign="middle">6 &#x2212;69 48</td>
<td align="center" valign="middle">&#x2212;5.926</td>
<td align="left" valign="middle">LECN</td>
<td align="left" valign="middle">MTG.L</td>
<td align="center" valign="middle">36</td>
<td align="center" valign="middle">&#x2212;60 &#x2212;24 &#x2212;6</td>
<td align="center" valign="middle">&#x2212;5.4793</td>
<td/>
<td align="left" valign="middle">ORBinf.L</td>
<td align="center" valign="middle">19</td>
<td align="center" valign="middle">&#x2212;42 33 &#x2013;3</td>
<td align="center" valign="middle">&#x2212;5.8723</td>
<td/>
<td align="left" valign="middle">MTG.L</td>
<td align="center" valign="middle">215</td>
<td align="center" valign="middle">&#x2212;57 &#x2212;48 24</td>
<td align="center" valign="middle">&#x2212;8.0241</td>
<td align="left" valign="middle">SMN</td>
<td align="left" valign="middle">PreCG.L</td>
<td align="center" valign="middle">63</td>
<td align="center" valign="middle">&#x2212;24 &#x2212;27 60</td>
<td align="center" valign="middle">&#x2212;5.0144</td>
<td/>
<td align="left" valign="middle">SMA.L</td>
<td align="center" valign="middle">133</td>
<td align="center" valign="middle">&#x2212;6 &#x2212;6 54</td>
<td align="center" valign="middle">&#x2212;5.1957</td>
<td align="left" valign="middle">VAN</td>
<td align="left" valign="middle">ITG.R</td>
<td align="center" valign="middle">42</td>
<td align="center" valign="middle">48 &#x2212;57 &#x2212;6</td>
<td align="center" valign="middle">&#x2212;4.7342</td>
<td/>
<td align="left" valign="middle">MTG.R</td>
<td align="center" valign="middle">55</td>
<td align="center" valign="middle">36 &#x2212;69 15</td>
<td align="center" valign="middle">&#x2212;5.2715</td>
<td/>
<td align="left" valign="middle">STG.R</td>
<td align="center" valign="middle">33</td>
<td align="center" valign="middle">57 &#x2212;36 15</td>
<td align="center" valign="middle">&#x2212;5.0471</td>
<td align="left" valign="middle">VN</td>
<td align="left" valign="middle">CAL.R</td>
<td align="center" valign="middle">318</td>
<td align="center" valign="middle">15 &#x2212;93 0</td>
<td align="center" valign="middle">&#x2212;9.7158</td></tr>
</tbody>
</table>
<table-wrap-foot>
<p>ROI-A, Brain regions with increased rsFC in each brain networks in &#x03B5;2 carriers; ROI-B, Brain regions with decreased rsFC in each brain networks in &#x03B5;2 carriers. AN, Auditory Network, DAN, Dorsal Attention Network, DMN, Default Mode Network, LECN, Left Executive Control Network, SMN, Somatomotor Network, VAN, Ventral Attention Network, VN, Visual Network. HES.L, left Heschl&#x2019;s gyrus; ROL.R, right Rolandic operculum; STG.R, right superior temporal gyrus; MTG.L, left middle temporal gyrus; IPL, inferior parietal, but supramarginal and angular gyrus; SOG.L, left superior occipital gyrus; MOG.R, right middle occipital gyrus; CAL.L, left calcarine fissure and surrounding cortex; CUN.L, left cuneus; PCUN.R, right precuneus; ANG.R, right angular gyrus; MFG.L, left middle frontal gyrus; ORBinf.L, left inferior frontal gyrus, orbital part; PCUN.L, left precuneus; PreCG.L, left precentral; SMA.L, left supplementary motor area; SMG.L, left supramarginal gyrus; ITG.R, right inferior temporal gyrus; MTG.R, right middle temporal gyrus; STG.R, right superior temporal gyrus; LING.L, left lingual gyrus; CAL.R, right calcarine fissure, and surrounding cortex.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec19">
<label>3.3.</label>
<title>Correlation between neuropsychological tests and ROIs</title>
<p>In the partial correlation analysis between ROI-A and neuropsychological after controlling for age, gender, education, and FDR correction, the brain region with rsFC increased in AN, DAN, DMN, LECN, VAN, and VN were positively correlated with MMSE. The brain region with rsFC increased in VN was positively correlated with SDMT, and the brain region with rsFC increased DMN was positively correlated with CVFT. In the partial correlation analysis between ROI-B and neuropsychological after controlling for age, gender, education, and FDR correction, he brain region with rsFC decreased in AN, DAN, SMN, VAN, and VN were negatively correlated with MMSE. Detailed information was summarized in <xref rid="fig3" ref-type="fig">Figure 3</xref>.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p><bold>(A)</bold> the map of Correlation coefficients between ROI-A and neuropsychological tests. <bold>(B)</bold> The map of Correlation coefficients between ROI-B and neuropsychological tests. &#x201C;&#x002A;&#x201D;: the correlation coefficient has been corrected by FDR; AN, auditory network; DAN, dorsal attention network; DMN, default mode network; LECN, left executive control network; SMN, somatomotor network; VAN, ventral attention network; VN, visual network. MMSE, mini-mental state examination; AVLT, auditory verbal learning test; ROCF, Rey-Osterrieth complex figure; SDMT, symbol digit modalities test; TMT, trail making test; SCWT, Stroop color and word test; CVFT, category verbal fluency test; BNT, boston naming test; CDT, clock drawing test.</p>
</caption>
<graphic xlink:href="fpsyt-14-1197987-g003.tif"/>
</fig>
</sec>
<sec id="sec20">
<label>3.4.</label>
<title>Difference in the GMV and the correlation between neuropsychological tests and ROIs</title>
<p>Compared with APOE &#x03B5;4 carriers, APOE &#x03B5;2 carriers had larger volumes of the thalamus and the right postcentral gyrus (PoCG.R). The volume of bilateral putamen of APOE &#x03B5;4 carriers was larger than that of APOE &#x03B5;2 carriers. The detailed coordinates and cluster size of the corrected differential brain regions are shown in <xref rid="tab3" ref-type="table">Table 3</xref>, and the location of the brain regions is shown in <xref rid="fig4" ref-type="fig">Figure 4</xref>. After GMV analyses of the whole brain between the two groups, these differential brain regions between two groups were defined as ROIs. Next, we extracted values of ROIs, respectively, and then calculated the Partial correlation with neuropsychological test scores, after controlling the age, gender, and education. Results showed that the volume of the thalamus was positively correlation with AVLT (N1-N3; r&#x2009;=&#x2009;0.285, <italic>p</italic> =&#x2009;0.027), and CVFT (r&#x2009;=&#x2009;0.322, <italic>p</italic> =&#x2009;0.012; <xref rid="fig5" ref-type="fig">Figures 5A</xref>,<xref rid="fig5" ref-type="fig">B</xref>). The volume of the PoCG.R was positively correlation with MMSE (r&#x2009;=&#x2009;0.287,<italic>p</italic> =&#x2009;0.026) and CVFT(r&#x2009;=&#x2009;0.265,<italic>p</italic> =&#x2009;0.040; <xref rid="fig5" ref-type="fig">Figures 5C</xref>,<xref rid="fig5" ref-type="fig">D</xref>). The volume of the left putamen was positively correlation with SCWT-C(time; r&#x2009;=&#x2009;0.258,<italic>p</italic> =&#x2009;0.047; <xref rid="fig5" ref-type="fig">Figure 5E</xref>). The volume of the right putamen was positively correlation with SCWT-C (time; r&#x2009;=&#x2009;0.322,p&#x2009;=&#x2009;0.012; <xref rid="fig5" ref-type="fig">Figure 5F</xref>).</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>Information of the brain regions after GMV analyses.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Brain regions</th>
<th align="center" valign="top">Cluster size</th>
<th align="center" valign="top">Coordinates (X Y Z)</th>
<th align="center" valign="top">Peak T-value</th></tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Thalamus</td>
<td align="center" valign="middle">1,211</td>
<td align="center" valign="middle">&#x2212;1.5 &#x2212;7.5 &#x2212;7.5</td>
<td align="center" valign="top">5.2867</td></tr>
<tr>
<td align="left" valign="middle">PoCG.R</td>
<td align="center" valign="middle">1,734</td>
<td align="center" valign="middle">58.5&#x2013;1.5 34.5</td>
<td align="center" valign="top">4.6252</td></tr>
<tr>
<td align="left" valign="middle">Putamen.R</td>
<td align="center" valign="middle">1,719</td>
<td align="center" valign="middle">&#x2212;30 &#x2212;4.5 7.5</td>
<td align="center" valign="top">&#x2212;4.4479</td></tr>
<tr>
<td align="left" valign="middle">Putamen.L</td>
<td align="center" valign="middle">1,454</td>
<td align="center" valign="middle">31.5 1.5 6</td>
<td align="center" valign="middle">&#x2212;4.7141</td></tr>
</tbody>
</table>
<table-wrap-foot>
<p>PoCG.R: right postcentral gyrus. L:left; R:right.</p>
</table-wrap-foot>
</table-wrap>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Differential brain regions between APOE &#x03B5;2 carriers and APOE &#x03B5;4 carriers after GMV analysis. Red: thalamus and right postcentral gyrus. Yellow: bilateral putamen.</p>
</caption>
<graphic xlink:href="fpsyt-14-1197987-g004.tif"/>
</fig>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>The correlation between differential brain regions after GMV analysis and neuropsychological (controlling age, gender, and education of partial correlation analysis). MMSE, mini-mental state examination; CVFT, category verbal fluency test; AVLT, auditory verbal learning test; SCWT, Stroop color and word test. PoCG.R, right posterior central gyrus. <bold>(A)</bold> The correlation between the thalamus and AVLT (N1-N3), <bold>(B)</bold> The correlation between the thalamus and CVFT, <bold>(C)</bold> The correlation between PoCG.R and MMSE, <bold>(D)</bold> The correlation between PoCG.R and CVFT, <bold>(E)</bold> The correlation between Putamen. L and SCWT-C (time), and <bold>(F)</bold> The correlation between Putamen.R and SCWT-C (time).</p>
</caption>
<graphic xlink:href="fpsyt-14-1197987-g005.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussions" id="sec21">
<label>4.</label>
<title>Discussion</title>
<sec id="sec22">
<label>4.1.</label>
<title>Differences in brain areas based on rs-fMRI</title>
<p>The ICA was used to assess the differences in RSNs between carriers of the cognitively protective APOE &#x03B5;2 allele and carriers of the deleterious APOE &#x03B5;4 allele. We found that in the seven differential RSNs, APOE &#x03B5;2 carriers had 10 brain regions with increased rsFC and 14 brain regions with decreased rsFC (removing the overlapping brain regions). Compared with APOE &#x03B5;4 carriers, APOE &#x03B5;2 carriers showed not many brain regions with increased rsFC in multiple brain networks, especially in DMN, SMN, and VAN. This result is not consistent with our second assumption that APOE &#x03B5;2 carriers with better cognition would have more brain regions with increased rsFC, particularly in DMN. An ICA study of patients with mild cognitive impairment (MCI) and normal controls found fluctuations in multiple brain networks between patients with MCI and normal controls, with normal controls showing no more areas of increased rsFC compared with MCI patients (<xref ref-type="bibr" rid="ref42">42</xref>). Some researchers argued that people with better cognitive function are able to economize on brain use and show better cognitive performance (<xref ref-type="bibr" rid="ref43">43</xref>). This might be the reason why APOE &#x03B5;2 carriers had a superior cognitive performance relative to APOE &#x03B5;4 carriers, though, the brain regions of increased rsFC are less than APOE &#x03B5;4 carriers. However, different brain regions have particular functions, for instance, Heschl&#x2019;s gyrus. A study on rs-fMRI of musicians found that the rsFC of Heschl&#x2019;s gyrus of musicians was significantly higher than that of normal people, which may explain why musicians are better at processing some sounds than normal (<xref ref-type="bibr" rid="ref44">44</xref>). Therefore, in our study, all differences in brain regions were evaluated in combination with cognitive performance between the two groups.</p>
<p>We individually calculated the correlation between ROI-A, ROI-B, and neuropsychological tests, <xref rid="fig3" ref-type="fig">Figure 3</xref>. In the Partial correlation analysis of ROI-A and neuropsychological tests, after controlling the age, gender, and education, we found in AN, DAN, DMN, LECN, VAN, and VN, the brain regions with increased rsFC were positively correlated with MMSE. From the perspective of the correlation coefficient, in addition to the weak correlation between VAN and MMSE, AN, DAN, DMN, LECN, and VN and MMSE all represent moderate correlation, which suggests that these brain regions with increased rsFC may lead to better general cognitive function and it may also be one of the reasons that the MMSE score of &#x03B5;2 carriers is significantly higher than that of &#x03B5;4 carriers (<italic>p</italic> &#x003C;&#x2009;0.001). In DMN, the brain region with increased rsFC was positively correlated with CVFT that was used to assess the language, and we could see that the average CVFT score of &#x03B5;2 carriers was higher than that of &#x03B5;4 carriers in <xref rid="tab1" ref-type="table">Table 1</xref>, though there was no significant (<italic>p</italic> =&#x2009;0.053). These results reflected that while the brain region with increased rsFC leads to better language, it might be not enough. In VN, the brain region with increased rsFC was positively correlated with SDMT which was used to assess attention. In SDMT, the subjects need constantly scanned the test paper to obtain symbols that match the numbers, and the brain regions associated with vision are highly active during this process, and concentration. Therefore, the brain region with increased rsFC in VN might be a reason why the SDMT score of &#x03B5;2 carriers was higher than &#x03B5;4 carriers (<italic>p</italic> =&#x2009;0.01). In the Partial correlation analysis of ROI-B and neuropsychological tests, after controlling the age, gender, and education. In AN, DAN, SMN, VAN, and VN, these brain regions with decreased rsFC were negatively correlated with MMSE. However, the increased rsFC and decreased rsFC were relative between the two groups, thus, these brain regions with decreased rsFC in &#x03B5;2 carriers were also the brain regions with rsFC increased in &#x03B5;4 carriers. These brain regions were negatively correlated with MMSE which also explains why the MMSE score of &#x03B5;4 carriers was lower than that of &#x03B5;2 carriers. Combined with these results, it is not difficult to find that the brain regions with increased rsFC in &#x03B5;2 carriers bring better cognitive performance to &#x03B5;2 carriers, and the brain regions with increased rsFC in &#x03B5;4 carriers make the cognitive performance of &#x03B5;4 carriers worse. This may be a mechanism for the brain to compensate for cognitive deficits (<xref ref-type="bibr" rid="ref42">42</xref>). Cognitive impairment does not necessarily result in fewer activated brain areas, but these activated brain areas are not associated with better cognition and may be compensated for poorer cognitive performance (<xref ref-type="bibr" rid="ref43">43</xref>).</p>
</sec>
<sec id="sec23">
<label>4.2.</label>
<title>Difference in brain areas based on structure MRI</title>
<p>GMV analysis of the whole brain showed that the thalamic and PoCG.R volume of APOE &#x03B5;2 carriers was higher than that of APOE &#x03B5;4 carriers; however, the bilateral putamen volume of APOE &#x03B5;4 carriers was higher than that of APOE &#x03B5;2 carriers. Although there were significant differences in the performance of the two groups in the memory cognitive domain, no difference in bilateral hippocampus volume was found between the two groups. The third assumption proposed previously is that the hippocampus volume of APOE &#x03B5;4 carriers is reduced relative to APOE &#x03B5;2 carriers, which was not verified. The thalamus plays a key role both non-specific projection systems and specific projection systems (<xref ref-type="bibr" rid="ref45">45</xref>). The primary sensory cortex is located in the postcentral gyrus, the main function is to receive somatic sensations from the opposite half of the body. A previous study has also shown that the postcentral gyrus plays an essential role in emotion regulation (<xref ref-type="bibr" rid="ref46">46</xref>). The thalamus and postcentral gyrus are the two major stations in the superficial sensory pathway, superficial sensory neurons are replaced in the thalamus and then finally project to the postcentral gyrus to produce a specific sensory (<xref ref-type="bibr" rid="ref45">45</xref>, <xref ref-type="bibr" rid="ref46">46</xref>). Asami et al. (<xref ref-type="bibr" rid="ref47">47</xref>) found that compared to healthy control, female patients with panic disorder had substantial reductions in the GMV in the thalamus bilaterally in a voxel-wise volume comparison analysis, they argued that the reduction in the thalamic volume is associated with emotion regulation and cognitive function. APOE &#x03B5;2 carriers had higher thalamic and PoCG.R volumes compared with APOE &#x03B5;4 carriers, suggesting that APOE &#x03B5;2 carriers might have more advantages in the processing of body surface sensation and emotion regulation compared with APOE &#x03B5;4 carriers. However, a longitudinal VBM study by Squarzoni et al. (<xref ref-type="bibr" rid="ref48">48</xref>) reported a reduced thalamic volume and hippocampal region in elderly healthy adults with the APOE &#x025B;4 non-carriers, and they argued that the reduction in the thalamic volume was not associated with APOE &#x025B;4. Our results are not consistent with Squarzoni&#x2019;s finding, which might be due to the different research methods and different participants.</p>
<p>Using fluorodeoxyglucose (FDG)-positron emission tomography (PET), Klunk et al. (<xref ref-type="bibr" rid="ref49">49</xref>) found extremely early amyloid deposition in the striatum, including putamen and caudate, in a high-risk Alzheimer&#x2019;s disease population, and this change was not associated with clinical symptoms. Using a similar method to that of Klunk and colleagues, Pardo and Lee (<xref ref-type="bibr" rid="ref50">50</xref>) also found that peak amyloid deposition localized principally to the putamen compared with other brain areas in non-dementia APOE &#x03B5;4 homozygotes. Kapoulea and Murphy (<xref ref-type="bibr" rid="ref51">51</xref>) used the structural MRI data and VBM-method and discovered that APOE &#x03B5;4 carriers among non-dementia older population possessed a larger volume of bilateral putamen compared with APOE &#x03B5;4 non-carriers but this change was not associated with cognitive performance. Kumar et al. (<xref ref-type="bibr" rid="ref52">52</xref>) discovered that newly-diagnosed patients with obstructive sleep apnea had a larger bilateral putamen volume than healthy control, which they believed was due to chronic hypoxia of obstructive sleep apnea patients. Compared with APOE &#x03B5;2 carriers, APOE &#x03B5;4 carriers had a larger volume of bilateral putamen. These results might have an explanation based on our findings and those from previous studies. It might be that additional amyloid was deposited in bilateral putamen in APOE &#x03B5;4 carriers (<xref ref-type="bibr" rid="ref49 ref50 ref51">49&#x2013;51</xref>), because APOE &#x03B5;4 allele possesses a high risk for amyloid deposition (<xref ref-type="bibr" rid="ref1">1</xref>, <xref ref-type="bibr" rid="ref53">53</xref>). Conversely, the APOE &#x03B5;2 allele had a low risk for amyloid deposition (<xref ref-type="bibr" rid="ref6">6</xref>, <xref ref-type="bibr" rid="ref7">7</xref>, <xref ref-type="bibr" rid="ref23">23</xref>). Therefore, the different sensitivity of APOE &#x03B5;2 and &#x03B5;4 carriers to the amyloid deposition could be an explanation for these results.</p>
<p>Finally, we calculated the Partial correlation between neuropsychological test scores and the value of ROIs after controlling the age, gender, and education to evaluate the impact of changed brain regions on cognitive function. We found that the thalamic volume positively correlated with AVLT (N1-N3) and CVFT, PoCG.R positively correlated with MMSE and CVFT, left putamen and right putamen positively correlated with SCWT-C(time). These results might indicate that the thalamus plays a role in IR and language. Fislage et al. (<xref ref-type="bibr" rid="ref54">54</xref>) computed the correlation between the thalamic volume and positive screening scales of postoperative delirium and found that a larger thalamic volume was associated with reduced odds of postoperative delirium. Zidan et al. (<xref ref-type="bibr" rid="ref55">55</xref>) inferred that thalamic volume loss could be an early sign of poorer cognitive performance in amnestic MCI. Our finding is consistent with data from previous studies, in which the thalamus plays a key role in cognitive performance (<xref ref-type="bibr" rid="ref45">45</xref>, <xref ref-type="bibr" rid="ref48">48</xref>). PoCG.R plays a role in general mental status and language, and may also be one of the reasons why the MMSE score of &#x03B5;2 carriers is significantly higher than that of &#x03B5;4 carriers. Although bilateral putamen was positively correlated with SCWT-C(time), this was not a good thing in terms of the definition of SCWT-C(time). The SCWT was used to assess the ability to inhibit cognitive interference, the longer SCWT-C(time) means the worse ability to inhibit cognitive interference (<xref ref-type="bibr" rid="ref36">36</xref>). This suggests that larger putamen volume corresponds to longer SCWT-C (time), indicating that the increase in putamen volume is not independent of cognition and may lead to worse executive function, though this is not consistent with Klunk et al. (<xref ref-type="bibr" rid="ref49">49</xref>) and Kapoulea and Murphy (<xref ref-type="bibr" rid="ref51">51</xref>) findings. The bilateral putamen volume of &#x03B5;2 carriers is smaller than that of &#x03B5;4 carriers, which may be the reason for the significant difference in SCWT-C(time) between the two groups. Taken together, the larger thalamus of &#x03B5;2 carriers and the volume of PoCG.R gave &#x03B5;2 carriers more advantages in general cognition, IR, and language, however, the larger putamen volume of &#x03B5;4 carriers actually made their cognitive performance worse. It might be that for &#x03B5;4 carriers with poor cognition, the function and volume of some brain regions are not all lower or smaller than that of &#x03B5;2 carriers with higher cognition, but these brain regions are not associated with better cognitive performance. Whether these results are caused by the different regulation of the same pathology by the two genotypes of &#x03B5;2 and &#x03B5;4 needs to be further verified in the future, but these results may explain to some extent why &#x03B5;2 carriers have better cognitive function than &#x03B5;4 carriers.</p>
</sec>
</sec>
<sec sec-type="conclusions" id="sec24">
<label>5.</label>
<title>Conclusion</title>
<p>In summary, the present study explored the differences in cognitive performance, brain structure, and function between the cognitively protective APOE &#x03B5;2 allele and cognitively impaired APOE &#x03B5;4 allele in non-dementia elderly carriers. It was found that cognitive differences between APOE &#x03B5;2 and &#x03B5;4 carriers are closely related to functional and GM differences, which are likely to cause cognitive differences between APOE &#x03B5;2 and &#x03B5;4 carriers. Therefore, a better understanding of the protective effects of the APOE &#x03B5;2 allele and the deleterious effects of the APOE &#x03B5;4 allele on human cognitive function is equally important. While these findings may be helpful in future clinical work, further research is needed to determine whether the thalamus, putamen, and PoCG.R could be potential imaging markers for the diagnosis of cognitive decline.</p>
</sec>
<sec sec-type="data-availability" id="sec25">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="sec26">
<title>Ethics statement</title>
<p>The studies involving humans were approved by The Ethics Committee of The Affiliated Hospital of Qingdao University. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="sec27">
<title>Author contributions</title>
<p>ZW and JP: conceptualization, methodology, formal analysis, writing &#x2013; original draft, and visualization. RZ, JQ, XS, BH, XM, and QW: data curation, investigation, methodology, project administration, software, and validation. JS: conceptualization, methodology, resources, supervision, project administration, and funding acquisition. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="funding-information" id="sec28">
<title>Funding</title>
<p>This study is supported by the National Key R&#x0026;D Program of China (2018YFC1315200).</p>
</sec>
<sec sec-type="COI-statement" id="sec29">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<p>The authors would like to thank the members of the MRI center of Department of Radiology, The Affiliated Hospital of Qingdao University.</p>
</ack>
<sec sec-type="supplementary-material" id="sec30">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1197987/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1197987/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.XLSX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>SUPPLEMENTARY TABLE 1</label>
<caption>
<p>Details of APOE e2 carriers</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_2.XLSX" id="SM2" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>SUPPLEMENTARY TABLE 2</label>
<caption>
<p>Details of APOE e4 carriers</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_3.XLSX" id="SM3" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>SUPPLEMENTARY TABLE 3</label>
<caption>
<p>Brain network differences between the two groups Details of brain regions</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_4.XLSX" id="SM4" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>SUPPLEMENTARY TABLE 4</label>
<caption>
<p>ROI-A extract values</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_5.XLSX" id="SM5" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>SUPPLEMENTARY TABLE 5</label>
<caption>
<p>ROI-B extract values</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_6.XLSX" id="SM6" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>SUPPLEMENTARY TABLE 6</label>
<caption>
<p>Differential brain area extraction after GMV analysis</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_7.XLSX" id="SM7" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>SUPPLEMENTARY TABLE 7</label>
<caption>
<p>Details of brain regions with gray matter differences between the two groups</p>
</caption>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loera-Valencia</surname><given-names>R</given-names></name> <name><surname>Cedazo-Minguez</surname><given-names>A</given-names></name> <name><surname>Kenigsberg</surname><given-names>PA</given-names></name> <name><surname>Page</surname><given-names>G</given-names></name> <name><surname>Duarte</surname><given-names>AI</given-names></name> <name><surname>Giusti</surname><given-names>P</given-names></name> <etal/></person-group>. <article-title>Current and emerging avenues for Alzheimer's disease drug targets</article-title>. <source>J Intern Med</source>. (<year>2019</year>) <volume>286</volume>:<fpage>398</fpage>&#x2013;<lpage>437</lpage>. doi: <pub-id pub-id-type="doi">10.1111/joim.12959</pub-id>, PMID: <pub-id pub-id-type="pmid">31286586</pub-id></citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Donoghue</surname><given-names>MC</given-names></name> <name><surname>Murphy</surname><given-names>SE</given-names></name> <name><surname>Zamboni</surname><given-names>G</given-names></name> <name><surname>Nobre</surname><given-names>AC</given-names></name> <name><surname>Mackay</surname><given-names>CE</given-names></name></person-group>. <article-title>APOE genotype and cognition in healthy individuals at risk of Alzheimer's disease: a review</article-title>. <source>Cortex</source>. (<year>2018</year>) <volume>104</volume>:<fpage>103</fpage>&#x2013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cortex.2018.03.025</pub-id>, PMID: <pub-id pub-id-type="pmid">29800787</pub-id></citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oboudiyat</surname><given-names>C</given-names></name> <name><surname>Glazer</surname><given-names>H</given-names></name> <name><surname>Seifan</surname><given-names>A</given-names></name> <name><surname>Greer</surname><given-names>C</given-names></name> <name><surname>Isaacson</surname><given-names>RS</given-names></name></person-group>. <article-title>Alzheimer's disease</article-title>. <source>Semin Neurol</source>. (<year>2013</year>) <volume>33</volume>:<fpage>313</fpage>&#x2013;<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1055/s-0033-1359319</pub-id></citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>S</given-names></name> <name><surname>Ghani</surname><given-names>M</given-names></name> <name><surname>Guo</surname><given-names>Z</given-names></name> <name><surname>Deming</surname><given-names>Y</given-names></name> <name><surname>Wang</surname><given-names>K</given-names></name> <name><surname>Sims</surname><given-names>R</given-names></name> <etal/></person-group>. <article-title>An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk</article-title>. <source>Neurobiol Aging</source>. (<year>2018</year>) <volume>66</volume>:<fpage>178.e1</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2017.12.027</pub-id>, PMID: <pub-id pub-id-type="pmid">29395286</pub-id></citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koutsodendris</surname><given-names>N</given-names></name> <name><surname>Nelson</surname><given-names>MR</given-names></name> <name><surname>Rao</surname><given-names>A</given-names></name> <name><surname>Huang</surname><given-names>Y</given-names></name></person-group>. <article-title>Apolipoprotein E and Alzheimer's disease: findings, hypotheses, and potential mechanisms</article-title>. <source>Annu Rev Pathol</source>. (<year>2022</year>) <volume>17</volume>:<fpage>73</fpage>&#x2013;<lpage>99</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev-pathmechdis-030421-112756</pub-id>, PMID: <pub-id pub-id-type="pmid">34460318</pub-id></citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Y</given-names></name> <name><surname>Yamada</surname><given-names>K</given-names></name> <name><surname>Liddelow</surname><given-names>SA</given-names></name> <name><surname>Smith</surname><given-names>ST</given-names></name> <name><surname>Zhao</surname><given-names>L</given-names></name> <name><surname>Luo</surname><given-names>W</given-names></name> <etal/></person-group>. <article-title>ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy</article-title>. <source>Nature</source>. (<year>2017</year>) <volume>549</volume>:<fpage>523</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature24016</pub-id>, PMID: <pub-id pub-id-type="pmid">28959956</pub-id></citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name> <name><surname>Shue</surname><given-names>F</given-names></name> <name><surname>Zhao</surname><given-names>N</given-names></name> <name><surname>Shinohara</surname><given-names>M</given-names></name> <name><surname>Bu</surname><given-names>G</given-names></name></person-group>. <article-title>APOE2: protective mechanism and therapeutic implications for Alzheimer's disease</article-title>. <source>Mol Neurodegener</source>. (<year>2020</year>) <volume>15</volume>:<fpage>63</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13024-020-00413-4</pub-id>, PMID: <pub-id pub-id-type="pmid">33148290</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wolters</surname><given-names>FJ</given-names></name> <name><surname>Yang</surname><given-names>Q</given-names></name> <name><surname>Biggs</surname><given-names>ML</given-names></name> <name><surname>Jakobsdottir</surname><given-names>J</given-names></name> <name><surname>Li</surname><given-names>S</given-names></name> <name><surname>Evans</surname><given-names>DS</given-names></name> <etal/></person-group>. <article-title>The impact of APOE genotype on survival: results of 38,537 participants from six population-based cohorts (E2-CHARGE)</article-title>. <source>PLoS One</source>. (<year>2019</year>) <volume>14</volume>:<fpage>e0219668</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0219668</pub-id>, PMID: <pub-id pub-id-type="pmid">31356640</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reiman</surname><given-names>EM</given-names></name> <name><surname>Arboleda-Velasquez</surname><given-names>JF</given-names></name> <name><surname>Quiroz</surname><given-names>YT</given-names></name> <name><surname>Huentelman</surname><given-names>MJ</given-names></name> <name><surname>Beach</surname><given-names>TG</given-names></name> <name><surname>Caselli</surname><given-names>RJ</given-names></name> <etal/></person-group>. <article-title>Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study</article-title>. <source>Nat Commun</source>. (<year>2020</year>) <volume>11</volume>:<fpage>667</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-019-14279-8</pub-id>, PMID: <pub-id pub-id-type="pmid">32015339</pub-id></citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marais</surname><given-names>AD</given-names></name></person-group>. <article-title>Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease</article-title>. <source>Pathology</source>. (<year>2019</year>) <volume>51</volume>:<fpage>165</fpage>&#x2013;<lpage>76</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pathol.2018.11.002</pub-id></citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Polvikoski</surname><given-names>T</given-names></name> <name><surname>Sulkava</surname><given-names>R</given-names></name> <name><surname>Haltia</surname><given-names>M</given-names></name> <name><surname>Kainulainen</surname><given-names>K</given-names></name> <name><surname>Vuorio</surname><given-names>A</given-names></name> <name><surname>Verkkoniemi</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein</article-title>. <source>N Engl J Med</source>. (<year>1995</year>) <volume>333</volume>:<fpage>1242</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1056/nejm199511093331902</pub-id></citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmechel</surname><given-names>DE</given-names></name> <name><surname>Saunders</surname><given-names>AM</given-names></name> <name><surname>Strittmatter</surname><given-names>WJ</given-names></name> <name><surname>Crain</surname><given-names>BJ</given-names></name> <name><surname>Hulette</surname><given-names>CM</given-names></name> <name><surname>Joo</surname><given-names>SH</given-names></name> <etal/></person-group>. <article-title>Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease</article-title>. <source>Proc Natl Acad Sci U S A</source>. (<year>1993</year>) <volume>90</volume>:<fpage>9649</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.90.20.9649</pub-id>, PMID: <pub-id pub-id-type="pmid">8415756</pub-id></citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serrano-Pozo</surname><given-names>A</given-names></name> <name><surname>Qian</surname><given-names>J</given-names></name> <name><surname>Monsell</surname><given-names>SE</given-names></name> <name><surname>Betensky</surname><given-names>RA</given-names></name> <name><surname>Hyman</surname><given-names>BT</given-names></name></person-group>. <article-title>APOE&#x03B5;2 is associated with milder clinical and pathological Alzheimer disease</article-title>. <source>Ann Neurol</source>. (<year>2015</year>) <volume>77</volume>:<fpage>917</fpage>&#x2013;<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ana.24369</pub-id>, PMID: <pub-id pub-id-type="pmid">25623662</pub-id></citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biswal</surname><given-names>B</given-names></name> <name><surname>Yetkin</surname><given-names>FZ</given-names></name> <name><surname>Haughton</surname><given-names>VM</given-names></name> <name><surname>Hyde</surname><given-names>JS</given-names></name></person-group>. <article-title>Functional connectivity in the motor cortex of resting human brain using echo-planar MRI</article-title>. <source>Magn Reson Med</source>. (<year>1995</year>) <volume>34</volume>:<fpage>537</fpage>&#x2013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1002/mrm.1910340409</pub-id>, PMID: <pub-id pub-id-type="pmid">8524021</pub-id></citation></ref>
<ref id="ref15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dennis</surname><given-names>EL</given-names></name> <name><surname>Thompson</surname><given-names>PM</given-names></name></person-group>. <article-title>Functional brain connectivity using fMRI in aging and Alzheimer's disease</article-title>. <source>Neuropsychol Rev</source>. (<year>2014</year>) <volume>24</volume>:<fpage>49</fpage>&#x2013;<lpage>62</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11065-014-9249-6</pub-id>, PMID: <pub-id pub-id-type="pmid">24562737</pub-id></citation></ref>
<ref id="ref16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Logothetis</surname><given-names>NK</given-names></name> <name><surname>Wandell</surname><given-names>BA</given-names></name></person-group>. <article-title>Interpreting the BOLD signal</article-title>. <source>Annu Rev Physiol</source>. (<year>2004</year>) <volume>66</volume>:<fpage>735</fpage>&#x2013;<lpage>69</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev.physiol.66.082602.092845</pub-id></citation></ref>
<ref id="ref17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>H</given-names></name> <name><surname>Wang</surname><given-names>Z</given-names></name> <name><surname>Tong</surname><given-names>E</given-names></name> <name><surname>Williams</surname><given-names>LM</given-names></name> <name><surname>Zaharchuk</surname><given-names>G</given-names></name> <name><surname>Zeineh</surname><given-names>M</given-names></name> <etal/></person-group>. <article-title>Resting-state functional MRI: everything that nonexperts have always wanted to know</article-title>. <source>AJNR Am J Neuroradiol</source>. (<year>2018</year>) <volume>39</volume>:<fpage>1390</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.3174/ajnr.A5527</pub-id>, PMID: <pub-id pub-id-type="pmid">29348136</pub-id></citation></ref>
<ref id="ref18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>K</given-names></name> <name><surname>Birn</surname><given-names>RM</given-names></name> <name><surname>Bandettini</surname><given-names>PA</given-names></name></person-group>. <article-title>Resting-state fMRI confounds and cleanup</article-title>. <source>NeuroImage</source>. (<year>2013</year>) <volume>80</volume>:<fpage>349</fpage>&#x2013;<lpage>59</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2013.04.001</pub-id>, PMID: <pub-id pub-id-type="pmid">23571418</pub-id></citation></ref>
<ref id="ref19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name> <name><surname>Chen</surname><given-names>K</given-names></name> <name><surname>Zhang</surname><given-names>J</given-names></name> <name><surname>Li</surname><given-names>X</given-names></name> <name><surname>Shu</surname><given-names>N</given-names></name> <name><surname>Wang</surname><given-names>J</given-names></name> <etal/></person-group>. <article-title>Disrupted functional and structural networks in cognitively normal elderly subjects with the APOE &#x025B;4 allele</article-title>. <source>Neuropsychopharmacology</source>. (<year>2015</year>) <volume>40</volume>:<fpage>1181</fpage>&#x2013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1038/npp.2014.302</pub-id>, PMID: <pub-id pub-id-type="pmid">25403724</pub-id></citation></ref>
<ref id="ref20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name> <name><surname>Wang</surname><given-names>J</given-names></name> <name><surname>He</surname><given-names>Y</given-names></name> <name><surname>Li</surname><given-names>H</given-names></name> <name><surname>Yuan</surname><given-names>H</given-names></name> <name><surname>Evans</surname><given-names>A</given-names></name> <etal/></person-group>. <article-title>Apolipoprotein E &#x03B5;4 modulates cognitive profiles, hippocampal volume, and resting-state functional connectivity in Alzheimer's disease</article-title>. <source>J Alzheimers Dis</source>. (<year>2015</year>) <volume>45</volume>:<fpage>781</fpage>&#x2013;<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.3233/jad-142556</pub-id>, PMID: <pub-id pub-id-type="pmid">25624419</pub-id></citation></ref>
<ref id="ref21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M</given-names></name> <name><surname>Bian</surname><given-names>C</given-names></name> <name><surname>Zhang</surname><given-names>J</given-names></name> <name><surname>Wen</surname><given-names>F</given-names></name></person-group>. <article-title>Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis</article-title>. <source>Sci Rep</source>. (<year>2014</year>) <volume>4</volume>:<fpage>4383</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep04383</pub-id>, PMID: <pub-id pub-id-type="pmid">24632849</pub-id></citation></ref>
<ref id="ref22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H</given-names></name> <name><surname>Devanand</surname><given-names>DP</given-names></name> <name><surname>Carlson</surname><given-names>S</given-names></name> <name><surname>Goldberg</surname><given-names>TE</given-names></name></person-group>. <article-title>Apolipoprotein E genotype e2: neuroprotection and its limits</article-title>. <source>Front Aging Neurosci</source>. (<year>2022</year>) <volume>14</volume>:<fpage>919712</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnagi.2022.919712</pub-id>, PMID: <pub-id pub-id-type="pmid">35912085</pub-id></citation></ref>
<ref id="ref23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suri</surname><given-names>S</given-names></name> <name><surname>Heise</surname><given-names>V</given-names></name> <name><surname>Trachtenberg</surname><given-names>AJ</given-names></name> <name><surname>Mackay</surname><given-names>CE</given-names></name></person-group>. <article-title>The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE &#x025B;2</article-title>. <source>Neurosci Biobehav Rev</source>. (<year>2013</year>) <volume>37</volume>:<fpage>2878</fpage>&#x2013;<lpage>86</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neubiorev.2013.10.010</pub-id>, PMID: <pub-id pub-id-type="pmid">24183852</pub-id></citation></ref>
<ref id="ref24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sando</surname><given-names>SB</given-names></name> <name><surname>Melquist</surname><given-names>S</given-names></name> <name><surname>Cannon</surname><given-names>A</given-names></name> <name><surname>Hutton</surname><given-names>ML</given-names></name> <name><surname>Sletvold</surname><given-names>O</given-names></name> <name><surname>Saltvedt</surname><given-names>I</given-names></name> <etal/></person-group>. <article-title>APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from Central Norway</article-title>. <source>BMC Neurol</source>. (<year>2008</year>) <volume>8</volume>:<fpage>9</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2377-8-9</pub-id>, PMID: <pub-id pub-id-type="pmid">18416843</pub-id></citation></ref>
<ref id="ref25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verghese</surname><given-names>PB</given-names></name> <name><surname>Castellano</surname><given-names>JM</given-names></name> <name><surname>Holtzman</surname><given-names>DM</given-names></name></person-group>. <article-title>Apolipoprotein E in Alzheimer's disease and other neurological disorders</article-title>. <source>Lancet Neurol</source>. (<year>2011</year>) <volume>10</volume>:<fpage>241</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s1474-4422(10)70325-2</pub-id>, PMID: <pub-id pub-id-type="pmid">21349439</pub-id></citation></ref>
<ref id="ref26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mckeown</surname><given-names>MJ</given-names></name> <name><surname>Makeig</surname><given-names>S</given-names></name> <name><surname>Brown</surname><given-names>GG</given-names></name> <name><surname>Jung</surname><given-names>TP</given-names></name> <name><surname>Kindermann</surname><given-names>SS</given-names></name> <name><surname>Bell</surname><given-names>AJ</given-names></name> <etal/></person-group>. <article-title>Analysis of fMRI data by blind separation into independent spatial components</article-title>. <source>Hum Brain Mapp</source>. (<year>1998</year>) <volume>6</volume>:<fpage>160</fpage>&#x2013;<lpage>88</lpage>. doi: <pub-id pub-id-type="doi">10.1002/(SICI)1097-0193(1998)6:3&#x003C;160::AID-HBM5&#x003E;3.0.CO;2-1</pub-id></citation></ref>
<ref id="ref27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>J</given-names></name> <name><surname>Friston</surname><given-names>KJ</given-names></name></person-group>. <article-title>Voxel-based morphometry--the methods</article-title>. <source>NeuroImage</source>. (<year>2000</year>) <volume>11</volume>:<fpage>805</fpage>&#x2013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.1006/nimg.2000.0582</pub-id></citation></ref>
<ref id="ref28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name> <name><surname>Li</surname><given-names>X</given-names></name> <name><surname>Zhang</surname><given-names>J</given-names></name> <name><surname>Chen</surname><given-names>Y</given-names></name> <name><surname>Li</surname><given-names>H</given-names></name> <name><surname>Wei</surname><given-names>D</given-names></name> <etal/></person-group>. <article-title>Early prevention of cognitive impairment in the community population: the Beijing aging brain rejuvenation initiative</article-title>. <source>Alzheimers Dement</source>. (<year>2021</year>) <volume>17</volume>:<fpage>1610</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1002/alz.12326</pub-id>, PMID: <pub-id pub-id-type="pmid">33792187</pub-id></citation></ref>
<ref id="ref29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Q</given-names></name> <name><surname>Lv</surname><given-names>Y</given-names></name> <name><surname>Zhou</surname><given-names>Y</given-names></name> <name><surname>Hong</surname><given-names>Z</given-names></name> <name><surname>Guo</surname><given-names>Q</given-names></name></person-group>. <article-title>Short-term delayed recall of auditory verbal learning test is equivalent to long-term delayed recall for identifying amnestic mild cognitive impairment</article-title>. <source>PLoS One</source>. (<year>2012</year>) <volume>7</volume>:<fpage>e51157</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0051157</pub-id>, PMID: <pub-id pub-id-type="pmid">23236445</pub-id></citation></ref>
<ref id="ref30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fastenau</surname><given-names>PS</given-names></name> <name><surname>Denburg</surname><given-names>NL</given-names></name> <name><surname>Hufford</surname><given-names>BJ</given-names></name></person-group>. <article-title>Adult norms for the Rey-Osterrieth complex figure test and for supplemental recognition and matching trials from the extended complex figure test</article-title>. <source>Clin Neuropsychol</source>. (<year>1999</year>) <volume>13</volume>:<fpage>30</fpage>&#x2013;<lpage>47</lpage>. doi: <pub-id pub-id-type="doi">10.1076/clin.13.1.30.1976</pub-id>, PMID: <pub-id pub-id-type="pmid">10937646</pub-id></citation></ref>
<ref id="ref31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>M</given-names></name> <name><surname>Shi</surname><given-names>J</given-names></name> <name><surname>Li</surname><given-names>T</given-names></name> <name><surname>Ni</surname><given-names>J</given-names></name> <name><surname>Zhang</surname><given-names>X</given-names></name> <name><surname>Li</surname><given-names>Y</given-names></name> <etal/></person-group>. <article-title>Diagnostic accuracy of the Chinese version of the trail-making test for screening cognitive impairment</article-title>. <source>J Am Geriatr Soc</source>. (<year>2018</year>) <volume>66</volume>:<fpage>92</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jgs.15135</pub-id>, PMID: <pub-id pub-id-type="pmid">29135021</pub-id></citation></ref>
<ref id="ref32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fellows</surname><given-names>RP</given-names></name> <name><surname>Schmitter-Edgecombe</surname><given-names>M</given-names></name></person-group>. <article-title>Symbol digit modalities test: regression-based normative data and clinical utility</article-title>. <source>Arch Clin Neuropsychol</source>. (<year>2019</year>) <volume>35</volume>:<fpage>105</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1093/arclin/acz020</pub-id>, PMID: <pub-id pub-id-type="pmid">31329813</pub-id></citation></ref>
<ref id="ref33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hazan</surname><given-names>E</given-names></name> <name><surname>Frankenburg</surname><given-names>F</given-names></name> <name><surname>Brenkel</surname><given-names>M</given-names></name> <name><surname>Shulman</surname><given-names>K</given-names></name></person-group>. <article-title>The test of time: a history of clock drawing</article-title>. <source>Int J Geriatr Psychiatry</source>. (<year>2018</year>) <volume>33</volume>:<fpage>e22</fpage>&#x2013;<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.1002/gps.4731</pub-id>, PMID: <pub-id pub-id-type="pmid">28556262</pub-id></citation></ref>
<ref id="ref34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cerhan</surname><given-names>JH</given-names></name> <name><surname>Ivnik</surname><given-names>RJ</given-names></name> <name><surname>Smith</surname><given-names>GE</given-names></name> <name><surname>Tangalos</surname><given-names>EC</given-names></name> <name><surname>Petersen</surname><given-names>RC</given-names></name> <name><surname>Boeve</surname><given-names>BF</given-names></name></person-group>. <article-title>Diagnostic utility of letter fluency, category fluency, and fluency difference scores in Alzheimer's disease</article-title>. <source>Clin Neuropsychol</source>. (<year>2002</year>) <volume>16</volume>:<fpage>35</fpage>&#x2013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1076/clin.16.1.35.8326</pub-id>, PMID: <pub-id pub-id-type="pmid">11992224</pub-id></citation></ref>
<ref id="ref35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>RW</given-names></name> <name><surname>Cheung</surname><given-names>MC</given-names></name> <name><surname>Chan</surname><given-names>AS</given-names></name></person-group>. <article-title>Confrontation naming in Chinese patients with left, right or bilateral brain damage</article-title>. <source>J Int Neuropsychol Soc</source>. (<year>2004</year>) <volume>10</volume>:<fpage>46</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1017/s1355617704101069</pub-id></citation></ref>
<ref id="ref36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scarpina</surname><given-names>F</given-names></name> <name><surname>Tagini</surname><given-names>S</given-names></name></person-group>. <article-title>The Stroop color and word test</article-title>. <source>Front Psychol</source>. (<year>2017</year>) <volume>8</volume>:<fpage>557</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyg.2017.00557</pub-id>, PMID: <pub-id pub-id-type="pmid">28446889</pub-id></citation></ref>
<ref id="ref37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seripa</surname><given-names>D</given-names></name> <name><surname>D'onofrio</surname><given-names>G</given-names></name> <name><surname>Panza</surname><given-names>F</given-names></name> <name><surname>Cascavilla</surname><given-names>L</given-names></name> <name><surname>Masullo</surname><given-names>C</given-names></name> <name><surname>Pilotto</surname><given-names>A</given-names></name></person-group>. <article-title>The genetics of the human APOE polymorphism</article-title>. <source>Rejuvenation Res</source>. (<year>2011</year>) <volume>14</volume>:<fpage>491</fpage>&#x2013;<lpage>500</lpage>. doi: <pub-id pub-id-type="doi">10.1089/rej.2011.1169</pub-id></citation></ref>
<ref id="ref38"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>D</given-names></name> <name><surname>Zhao</surname><given-names>H</given-names></name> <name><surname>Gu</surname><given-names>H</given-names></name> <name><surname>Han</surname><given-names>B</given-names></name> <name><surname>Wang</surname><given-names>Q</given-names></name> <name><surname>Man</surname><given-names>X</given-names></name> <etal/></person-group>. <article-title>The effects of rs405509 on APOE&#x03B5;4 non-carriers in non-demented aging</article-title>. <source>Front Neurosci</source>. (<year>2021</year>) <volume>15</volume>:<fpage>677823</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnins.2021.677823</pub-id>, PMID: <pub-id pub-id-type="pmid">34177454</pub-id></citation></ref>
<ref id="ref39"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smitha</surname><given-names>KA</given-names></name> <name><surname>Akhil Raja</surname><given-names>K</given-names></name> <name><surname>Arun</surname><given-names>KM</given-names></name> <name><surname>Rajesh</surname><given-names>PG</given-names></name> <name><surname>Thomas</surname><given-names>B</given-names></name> <name><surname>Kapilamoorthy</surname><given-names>TR</given-names></name> <etal/></person-group>. <article-title>Resting state fMRI: a review on methods in resting state connectivity analysis and resting state networks</article-title>. <source>Neuroradiol J</source>. (<year>2017</year>) <volume>30</volume>:<fpage>305</fpage>&#x2013;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.1177/1971400917697342</pub-id>, PMID: <pub-id pub-id-type="pmid">28353416</pub-id></citation></ref>
<ref id="ref40"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calhoun</surname><given-names>VD</given-names></name> <name><surname>Adali</surname><given-names>T</given-names></name> <name><surname>Pearlson</surname><given-names>GD</given-names></name> <name><surname>Pekar</surname><given-names>JJ</given-names></name></person-group>. <article-title>A method for making group inferences from functional MRI data using independent component analysis</article-title>. <source>Hum Brain Mapp</source>. (<year>2001</year>) <volume>14</volume>:<fpage>140</fpage>&#x2013;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1002/hbm.1048</pub-id>, PMID: <pub-id pub-id-type="pmid">11559959</pub-id></citation></ref>
<ref id="ref41"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Damoiseaux</surname><given-names>JS</given-names></name> <name><surname>Rombouts</surname><given-names>SA</given-names></name> <name><surname>Barkhof</surname><given-names>F</given-names></name> <name><surname>Scheltens</surname><given-names>P</given-names></name> <name><surname>Stam</surname><given-names>CJ</given-names></name> <name><surname>Smith</surname><given-names>SM</given-names></name> <etal/></person-group>. <article-title>Consistent resting-state networks across healthy subjects</article-title>. <source>Proc Natl Acad Sci U S A</source>. (<year>2006</year>) <volume>103</volume>:<fpage>13848</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0601417103</pub-id>, PMID: <pub-id pub-id-type="pmid">16945915</pub-id></citation></ref>
<ref id="ref42"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bi</surname><given-names>XA</given-names></name> <name><surname>Sun</surname><given-names>Q</given-names></name> <name><surname>Zhao</surname><given-names>J</given-names></name> <name><surname>Xu</surname><given-names>Q</given-names></name> <name><surname>Wang</surname><given-names>L</given-names></name></person-group>. <article-title>Non-linear ICA analysis of resting-state fMRI in mild cognitive impairment</article-title>. <source>Front Neurosci</source>. (<year>2018</year>) <volume>12</volume>:<fpage>413</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnins.2018.00413</pub-id>, PMID: <pub-id pub-id-type="pmid">29970984</pub-id></citation></ref>
<ref id="ref43"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>Y</given-names></name> <name><surname>Barnes</surname><given-names>CA</given-names></name> <name><surname>Grady</surname><given-names>C</given-names></name> <name><surname>Jones</surname><given-names>RN</given-names></name> <name><surname>Raz</surname><given-names>N</given-names></name></person-group>. <article-title>Brain reserve, cognitive reserve, compensation, and maintenance: operationalization, validity, and mechanisms of cognitive resilience</article-title>. <source>Neurobiol Aging</source>. (<year>2019</year>) <volume>83</volume>:<fpage>124</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2019.03.022</pub-id>, PMID: <pub-id pub-id-type="pmid">31732015</pub-id></citation></ref>
<ref id="ref44"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benner</surname><given-names>J</given-names></name> <name><surname>Wengenroth</surname><given-names>M</given-names></name> <name><surname>Reinhardt</surname><given-names>J</given-names></name> <name><surname>Stippich</surname><given-names>C</given-names></name> <name><surname>Schneider</surname><given-names>P</given-names></name> <name><surname>Blatow</surname><given-names>M</given-names></name></person-group>. <article-title>Prevalence and function of Heschl's gyrus morphotypes in musicians</article-title>. <source>Brain Struct Funct</source>. (<year>2017</year>) <volume>222</volume>:<fpage>3587</fpage>&#x2013;<lpage>603</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00429-017-1419-x</pub-id>, PMID: <pub-id pub-id-type="pmid">28397108</pub-id></citation></ref>
<ref id="ref45"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sherman</surname><given-names>SM</given-names></name></person-group>. <article-title>Interneurons and triadic circuitry of the thalamus</article-title>. <source>Trends Neurosci</source>. (<year>2004</year>) <volume>27</volume>:<fpage>670</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tins.2004.08.003</pub-id>, PMID: <pub-id pub-id-type="pmid">15474167</pub-id></citation></ref>
<ref id="ref46"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kropf</surname><given-names>E</given-names></name> <name><surname>Syan</surname><given-names>SK</given-names></name> <name><surname>Minuzzi</surname><given-names>L</given-names></name> <name><surname>Frey</surname><given-names>BN</given-names></name></person-group>. <article-title>From anatomy to function: the role of the somatosensory cortex in emotional regulation</article-title>. <source>Braz J Psychiatry</source>. (<year>2019</year>) <volume>41</volume>:<fpage>261</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1590/1516-4446-2018-0183</pub-id>, PMID: <pub-id pub-id-type="pmid">30540029</pub-id></citation></ref>
<ref id="ref47"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Asami</surname><given-names>T</given-names></name> <name><surname>Yoshida</surname><given-names>H</given-names></name> <name><surname>Takaishi</surname><given-names>M</given-names></name> <name><surname>Nakamura</surname><given-names>R</given-names></name> <name><surname>Yoshimi</surname><given-names>A</given-names></name> <name><surname>Whitford</surname><given-names>TJ</given-names></name> <etal/></person-group>. <article-title>Thalamic shape and volume abnormalities in female patients with panic disorder</article-title>. <source>PLoS One</source>. (<year>2018</year>) <volume>13</volume>:<fpage>e0208152</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0208152</pub-id>, PMID: <pub-id pub-id-type="pmid">30566534</pub-id></citation></ref>
<ref id="ref48"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Squarzoni</surname><given-names>P</given-names></name> <name><surname>Duran</surname><given-names>FLS</given-names></name> <name><surname>Busatto</surname><given-names>GF</given-names></name> <name><surname>Alves</surname><given-names>T</given-names></name></person-group>. <article-title>Reduced Gray matter volume of the thalamus and hippocampal region in elderly healthy adults with no impact of APOE &#x025B;4: a longitudinal voxel-based morphometry study</article-title>. <source>J Alzheimers Dis</source>. (<year>2018</year>) <volume>62</volume>:<fpage>757</fpage>&#x2013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.3233/jad-161036</pub-id>, PMID: <pub-id pub-id-type="pmid">29480170</pub-id></citation></ref>
<ref id="ref49"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klunk</surname><given-names>WE</given-names></name> <name><surname>Price</surname><given-names>JC</given-names></name> <name><surname>Mathis</surname><given-names>CA</given-names></name> <name><surname>Tsopelas</surname><given-names>ND</given-names></name> <name><surname>Lopresti</surname><given-names>BJ</given-names></name> <name><surname>Ziolko</surname><given-names>SK</given-names></name> <etal/></person-group>. <article-title>Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees</article-title>. <source>J Neurosci</source>. (<year>2007</year>) <volume>27</volume>:<fpage>6174</fpage>&#x2013;<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1523/jneurosci.0730-07.2007</pub-id>, PMID: <pub-id pub-id-type="pmid">17553989</pub-id></citation></ref>
<ref id="ref50"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pardo</surname><given-names>JV</given-names></name> <name><surname>Lee</surname><given-names>JT</given-names></name></person-group>. <article-title>Atypical localization and dissociation between glucose uptake and amyloid deposition in cognitively Normal APOE&#x002A;E4 Homozygotic elders compared with patients with late-onset Alzheimer's disease</article-title>. <source>eNeuro</source>. (<year>2018</year>) <volume>5</volume>:<fpage>ENEURO.0396</fpage>&#x2013;<lpage>17.2018</lpage>. doi: <pub-id pub-id-type="doi">10.1523/eneuro.0396-17.2018</pub-id>, PMID: <pub-id pub-id-type="pmid">29497704</pub-id></citation></ref>
<ref id="ref51"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kapoulea</surname><given-names>EA</given-names></name> <name><surname>Murphy</surname><given-names>C</given-names></name></person-group>. <article-title>Older, non-demented apolipoprotein &#x03B5;(4) carrier males show hyperactivation and structural differences in odor memory regions: a blood-oxygen-level-dependent and structural magnetic resonance imaging study</article-title>. <source>Neurobiol Aging</source>. (<year>2020</year>) <volume>93</volume>:<fpage>25</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2020.04.013</pub-id>, PMID: <pub-id pub-id-type="pmid">32447009</pub-id></citation></ref>
<ref id="ref52"><label>52.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>R</given-names></name> <name><surname>Farahvar</surname><given-names>S</given-names></name> <name><surname>Ogren</surname><given-names>JA</given-names></name> <name><surname>Macey</surname><given-names>PM</given-names></name> <name><surname>Thompson</surname><given-names>PM</given-names></name> <name><surname>Woo</surname><given-names>MA</given-names></name> <etal/></person-group>. <article-title>Brain putamen volume changes in newly-diagnosed patients with obstructive sleep apnea</article-title>. <source>Neuroimage Clin</source>. (<year>2014</year>) <volume>4</volume>:<fpage>383</fpage>&#x2013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.nicl.2014.01.009</pub-id>, PMID: <pub-id pub-id-type="pmid">24567910</pub-id></citation></ref>
<ref id="ref53"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roses</surname><given-names>AD</given-names></name> <name><surname>Saunders</surname><given-names>AM</given-names></name></person-group>. <article-title>APOE is a major susceptibility gene for Alzheimer's disease</article-title>. <source>Curr Opin Biotechnol</source>. (<year>1994</year>) <volume>5</volume>:<fpage>663</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0958-1669(94)90091-4</pub-id>, PMID: <pub-id pub-id-type="pmid">7765750</pub-id></citation></ref>
<ref id="ref54"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fislage</surname><given-names>M</given-names></name> <name><surname>Feinkohl</surname><given-names>I</given-names></name> <name><surname>Pischon</surname><given-names>T</given-names></name> <name><surname>Spies</surname><given-names>CD</given-names></name> <name><surname>Borchers</surname><given-names>F</given-names></name> <name><surname>Winterer</surname><given-names>G</given-names></name> <etal/></person-group>. <article-title>Presurgical thalamus volume in postoperative delirium: a longitudinal observational cohort study in older patients</article-title>. <source>Anesth Analg</source>. (<year>2022</year>) <volume>135</volume>:<fpage>136</fpage>&#x2013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1213/ane.0000000000005987</pub-id>, PMID: <pub-id pub-id-type="pmid">35442218</pub-id></citation></ref>
<ref id="ref55"><label>55.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zidan</surname><given-names>M</given-names></name> <name><surname>Boban</surname><given-names>J</given-names></name> <name><surname>Bjelan</surname><given-names>M</given-names></name> <name><surname>Todorovi&#x0107;</surname><given-names>A</given-names></name> <name><surname>Stankov Vujani&#x0107;</surname><given-names>T</given-names></name> <name><surname>Semnic</surname><given-names>M</given-names></name> <etal/></person-group>. <article-title>Thalamic volume loss as an early sign of amnestic mild cognitive impairment</article-title>. <source>J Clin Neurosci</source>. (<year>2019</year>) <volume>68</volume>:<fpage>168</fpage>&#x2013;<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jocn.2019.07.004</pub-id>, PMID: <pub-id pub-id-type="pmid">31324472</pub-id></citation></ref>
</ref-list>
<fn-group><fn id="fn0001"><p><sup>1</sup><ext-link xlink:href="http://restfmri.net/forum/RESTplus" ext-link-type="uri">http://restfmri.net/forum/RESTplus</ext-link></p></fn>
<fn id="fn0002"><p><sup>2</sup><ext-link xlink:href="http://www.fil.ion.ucl.ac.uk/spm" ext-link-type="uri">http://www.fil.ion.ucl.ac.uk/spm</ext-link></p></fn>
<fn id="fn0003"><p><sup>3</sup><ext-link xlink:href="http://www.nitrc.org/projects/dcm2nii/" ext-link-type="uri">www.nitrc.org/projects/dcm2nii/</ext-link></p></fn></fn-group>
</back>
</article>